JP2003528810A

JP2003528810A - メラノコルチン−４受容体結合化合物及びその使用方法

メラノコルチン−４受容体結合化合物及びその使用方法

Info

Publication number: JP2003528810A
Authority: JP; Japan
Prior art keywords: phenyl; methoxy; tetrahydro; pyrimidine; benzylsulfanyl
Prior art date: 1999-08-04
Legal status : Pending

Application number

JP2001515309A

Other languages

English (en)

Japanese (ja)

Other versions

JP2003528810A5 (https=

Inventor

マーティンピーマグワイア

ミンシダイ

トリシアジェイヴォス

Original Assignee

ミレニアムファーマスーティカルズインク

Priority date

1999-08-04

Filing date

2000-08-04

Publication date

2003-09-30

2000-08-04 Application filed by ミレニアムファーマスーティカルズインク filed Critical ミレニアムファーマスーティカルズインク

2003-09-30 Publication of JP2003528810A publication Critical patent/JP2003528810A/ja

2007-09-20 Publication of JP2003528810A5 publication Critical patent/JP2003528810A5/ja

Status Pending legal-status Critical Current

Links

150000001875 compounds Chemical class 0.000 title claims abstract description 436
238000000034 method Methods 0.000 title claims abstract description 292
108010021436 Type 4 Melanocortin Receptor Proteins 0.000 title description 242
102000001796 Melanocortin 4 receptors Human genes 0.000 title 1
102100023724 Melanocortin receptor 4 Human genes 0.000 claims abstract description 89
230000004580 weight loss Effects 0.000 claims abstract description 16
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 13
101710085775 Melanocortin receptor 4 Proteins 0.000 claims abstract 88
-1 amino, amidino, guanidino Chemical group 0.000 claims description 718
125000000217 alkyl group Chemical group 0.000 claims description 257
125000003118 aryl group Chemical group 0.000 claims description 152
125000000623 heterocyclic group Chemical group 0.000 claims description 112
125000003342 alkenyl group Chemical group 0.000 claims description 109
125000000304 alkynyl group Chemical group 0.000 claims description 104
125000003545 alkoxy group Chemical group 0.000 claims description 92
239000001257 hydrogen Substances 0.000 claims description 92
229910052739 hydrogen Inorganic materials 0.000 claims description 92
229910052736 halogen Inorganic materials 0.000 claims description 90
150000002367 halogens Chemical class 0.000 claims description 84
125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 76
229910052799 carbon Inorganic materials 0.000 claims description 71
125000004093 cyano group Chemical group *C#N 0.000 claims description 61
150000003839 salts Chemical class 0.000 claims description 60
229910052757 nitrogen Inorganic materials 0.000 claims description 56
125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 55
229910052717 sulfur Inorganic materials 0.000 claims description 52
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 50
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 50
241000124008 Mammalia Species 0.000 claims description 48
239000000203 mixture Substances 0.000 claims description 47
125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 47
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 46
150000001721 carbon Chemical group 0.000 claims description 46
125000001424 substituent group Chemical group 0.000 claims description 46
125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 44
125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 44
125000002252 acyl group Chemical group 0.000 claims description 42
229910052760 oxygen Inorganic materials 0.000 claims description 41
239000008194 pharmaceutical composition Substances 0.000 claims description 41
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 40
125000004448 alkyl carbonyl group Chemical group 0.000 claims description 39
125000004122 cyclic group Chemical group 0.000 claims description 39
125000001624 naphthyl group Chemical group 0.000 claims description 39
125000001072 heteroaryl group Chemical group 0.000 claims description 36
125000004433 nitrogen atom Chemical group N* 0.000 claims description 34
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 33
NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 32
239000001301 oxygen Substances 0.000 claims description 32
239000011593 sulfur Substances 0.000 claims description 32
125000003710 aryl alkyl group Chemical group 0.000 claims description 30
239000000460 chlorine Substances 0.000 claims description 30
229910052801 chlorine Inorganic materials 0.000 claims description 30
OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Substances OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 29
239000011737 fluorine Substances 0.000 claims description 28
229910052731 fluorine Inorganic materials 0.000 claims description 28
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 28
ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 27
PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 27
WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 26
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 26
GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 26
229910052794 bromium Inorganic materials 0.000 claims description 26
125000004663 dialkyl amino group Chemical group 0.000 claims description 25
RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Substances C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims description 24
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 23
239000003814 drug Substances 0.000 claims description 21
150000005347 biaryls Chemical group 0.000 claims description 20
125000004429 atom Chemical group 0.000 claims description 18
125000005842 heteroatom Chemical group 0.000 claims description 18
239000003937 drug carrier Substances 0.000 claims description 16
125000005647 linker group Chemical group 0.000 claims description 16
SBOJXQVPLKSXOG-UHFFFAOYSA-N o-amino-hydroxylamine Chemical class NON SBOJXQVPLKSXOG-UHFFFAOYSA-N 0.000 claims description 16
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 15
239000002253 acid Substances 0.000 claims description 15
125000004432 carbon atom Chemical group C* 0.000 claims description 15
RWRDLPDLKQPQOW-UHFFFAOYSA-N tetrahydropyrrole Substances C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 claims description 15
208000016261 weight loss Diseases 0.000 claims description 15
150000002148 esters Chemical class 0.000 claims description 14
GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 claims description 13
125000005099 aryl alkyl carbonyl group Chemical group 0.000 claims description 13
125000000753 cycloalkyl group Chemical group 0.000 claims description 13
UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 12
206010006895 Cachexia Diseases 0.000 claims description 12
125000003277 amino group Chemical group 0.000 claims description 12
229910014033 C-OH Inorganic materials 0.000 claims description 11
229910014570 C—OH Inorganic materials 0.000 claims description 11
125000003367 polycyclic group Chemical group 0.000 claims description 11
125000000714 pyrimidinyl group Chemical group 0.000 claims description 11
150000003568 thioethers Chemical class 0.000 claims description 11
239000003795 chemical substances by application Substances 0.000 claims description 10
125000004076 pyridyl group Chemical group 0.000 claims description 10
125000000168 pyrrolyl group Chemical group 0.000 claims description 10
125000004434 sulfur atom Chemical group 0.000 claims description 10
MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims description 9
125000004104 aryloxy group Chemical group 0.000 claims description 9
125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 9
125000003386 piperidinyl group Chemical group 0.000 claims description 9
KWBJMDZAPHKDFB-UHFFFAOYSA-N 1-[[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]phenyl]methyl]piperidine Chemical compound COC1=CC=C(Br)C=C1CSC1=CC=CC=C1CN1CCCCC1 KWBJMDZAPHKDFB-UHFFFAOYSA-N 0.000 claims description 8
DYASGHCSJCHRAM-UHFFFAOYSA-N 1-[[3-fluoro-2-(2-naphthalen-1-ylethyl)phenyl]methyl]piperazine Chemical compound C=1C=CC2=CC=CC=C2C=1CCC=1C(F)=CC=CC=1CN1CCNCC1 DYASGHCSJCHRAM-UHFFFAOYSA-N 0.000 claims description 8
QRDFGAHATXGIBR-UHFFFAOYSA-N 2-[2-[(2-methoxy-5-nitrophenyl)methoxy]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C([N+]([O-])=O)C=C1COC1=CC=CC=C1C1=NCCCN1 QRDFGAHATXGIBR-UHFFFAOYSA-N 0.000 claims description 8
VBUILYKEAPKRKE-UHFFFAOYSA-N 2-[[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]phenyl]methyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(Br)C=C1CSC1=CC=CC=C1CC1=NCCCN1 VBUILYKEAPKRKE-UHFFFAOYSA-N 0.000 claims description 8
239000005557 antagonist Substances 0.000 claims description 8
125000002837 carbocyclic group Chemical group 0.000 claims description 8
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 8
ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 claims description 8
125000003373 pyrazinyl group Chemical group 0.000 claims description 8
125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 claims description 8
GLGIWLZTKPEBKS-UHFFFAOYSA-N 2-[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]phenyl]-6-ethyl-1,4,5,6-tetrahydropyrimidine Chemical compound N1C(CC)CCN=C1C1=CC=CC=C1SCC1=CC(Br)=CC=C1OC GLGIWLZTKPEBKS-UHFFFAOYSA-N 0.000 claims description 7
125000004103 aminoalkyl group Chemical group 0.000 claims description 7
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 7
125000002619 bicyclic group Chemical group 0.000 claims description 7
XYZDDOTYDXXWPM-UHFFFAOYSA-N n-[[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]phenyl]methyl]-n-ethylethanamine Chemical compound CCN(CC)CC1=CC=CC=C1SCC1=CC(Br)=CC=C1OC XYZDDOTYDXXWPM-UHFFFAOYSA-N 0.000 claims description 7
125000004430 oxygen atom Chemical group O* 0.000 claims description 7
125000001544 thienyl group Chemical group 0.000 claims description 7
239000000556 agonist Substances 0.000 claims description 6
125000001207 fluorophenyl group Chemical group 0.000 claims description 6
230000019612 pigmentation Effects 0.000 claims description 6
125000004193 piperazinyl group Chemical group 0.000 claims description 6
125000003396 thiol group Chemical group [H]S* 0.000 claims description 6
CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 claims description 5
125000002393 azetidinyl group Chemical group 0.000 claims description 5
208000035475 disorder Diseases 0.000 claims description 5
125000005843 halogen group Chemical group 0.000 claims description 5
125000002883 imidazolyl group Chemical group 0.000 claims description 5
SHZPSAKOOSXLBB-UHFFFAOYSA-N 1-(naphthalen-1-ylmethyl)-3-(2-phenylethyl)-1-(2-piperidin-1-ylethyl)thiourea Chemical compound C1CCCCN1CCN(CC=1C2=CC=CC=C2C=CC=1)C(=S)NCCC1=CC=CC=C1 SHZPSAKOOSXLBB-UHFFFAOYSA-N 0.000 claims description 4
GIHQQJIHBAIGSO-UHFFFAOYSA-N 1-[2-(2-naphthalen-1-ylethyl)phenyl]ethane-1,2-diamine Chemical compound NCC(N)C1=CC=CC=C1CCC1=CC=CC2=CC=CC=C12 GIHQQJIHBAIGSO-UHFFFAOYSA-N 0.000 claims description 4
ATZDPWOFOKHOFM-UHFFFAOYSA-N 1-[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]phenyl]-n,n-dimethylmethanamine Chemical compound COC1=CC=C(Br)C=C1CSC1=CC=CC=C1CN(C)C ATZDPWOFOKHOFM-UHFFFAOYSA-N 0.000 claims description 4
RCAPUOMCNFOSTP-UHFFFAOYSA-N 1-[4-methoxy-3-[[2-(1,4,5,6-tetrahydropyrimidin-2-yl)phenyl]sulfanylmethyl]phenyl]ethanone Chemical compound COC1=CC=C(C(C)=O)C=C1CSC1=CC=CC=C1C1=NCCCN1 RCAPUOMCNFOSTP-UHFFFAOYSA-N 0.000 claims description 4
UPUQOEPOWHSGPH-UHFFFAOYSA-N 1-[[2-(2-naphthalen-1-ylethyl)phenyl]methyl]piperazine Chemical compound C=1C=CC2=CC=CC=C2C=1CCC1=CC=CC=C1CN1CCNCC1 UPUQOEPOWHSGPH-UHFFFAOYSA-N 0.000 claims description 4
UWBWBCKISPTABJ-UHFFFAOYSA-N 1-[[2-(2-naphthalen-1-ylethyl)phenyl]methyl]pyrrolidin-3-amine Chemical compound C1C(N)CCN1CC1=CC=CC=C1CCC1=CC=CC2=CC=CC=C12 UWBWBCKISPTABJ-UHFFFAOYSA-N 0.000 claims description 4
IILSKIZWMSVWAI-UHFFFAOYSA-N 1-[[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]phenyl]methyl]piperazine Chemical compound COC1=CC=C(Br)C=C1CSC1=CC=CC=C1CN1CCNCC1 IILSKIZWMSVWAI-UHFFFAOYSA-N 0.000 claims description 4
SYACJNJDWOFLPR-UHFFFAOYSA-N 2-(2-benzylsulfanylphenyl)-1,4,5,6-tetrahydropyrimidine Chemical compound C=1C=CC=CC=1CSC1=CC=CC=C1C1=NCCCN1 SYACJNJDWOFLPR-UHFFFAOYSA-N 0.000 claims description 4
KGUYGXACOPYBBV-UHFFFAOYSA-N 2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]-3-(1,4,5,6-tetrahydropyrimidin-2-yl)pyrazine Chemical compound COC1=CC=C(Br)C=C1CSC1=NC=CN=C1C1=NCCCN1 KGUYGXACOPYBBV-UHFFFAOYSA-N 0.000 claims description 4
SVPBPRSLWASWKI-UHFFFAOYSA-N 2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]-3-piperazin-1-yl-6,7-dihydroquinoxaline Chemical compound COC1=CC=C(Br)C=C1CSC1=NC2=CCCC=C2N=C1N1CCNCC1 SVPBPRSLWASWKI-UHFFFAOYSA-N 0.000 claims description 4
SCCAFPIBEOBGTQ-UHFFFAOYSA-N 2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]benzenecarboximidamide Chemical compound COC1=CC=C(Br)C=C1CSC1=CC=CC=C1C(N)=N SCCAFPIBEOBGTQ-UHFFFAOYSA-N 0.000 claims description 4
ACJPYKJBCKVDIV-UHFFFAOYSA-N 2-[2-(2-naphthalen-1-ylethyl)-3-(trifluoromethyl)phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound C=1C=CC2=CC=CC=C2C=1CCC=1C(C(F)(F)F)=CC=CC=1C1=NCCCN1 ACJPYKJBCKVDIV-UHFFFAOYSA-N 0.000 claims description 4
RTLGWGUKVAYFGQ-UHFFFAOYSA-N 2-[2-(2-naphthalen-1-ylethyl)phenyl]ethanamine Chemical compound NCCC1=CC=CC=C1CCC1=CC=CC2=CC=CC=C12 RTLGWGUKVAYFGQ-UHFFFAOYSA-N 0.000 claims description 4
HQKSAFODQJVAMY-UHFFFAOYSA-N 2-[2-(9h-fluoren-9-ylsulfanyl)phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound C1CCNC(C=2C(=CC=CC=2)SC2C3=CC=CC=C3C3=CC=CC=C32)=N1 HQKSAFODQJVAMY-UHFFFAOYSA-N 0.000 claims description 4
ZLJUCWCUFIZEDW-UHFFFAOYSA-N 2-[2-[(2,5-dichlorophenyl)sulfanylmethyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound ClC1=CC=C(Cl)C(SCC=2C(=CC=CC=2)C=2NCCCN=2)=C1 ZLJUCWCUFIZEDW-UHFFFAOYSA-N 0.000 claims description 4
USWIGGWFARNAIT-UHFFFAOYSA-N 2-[2-[(2,5-dimethylphenyl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound CC1=CC=C(C)C(CSC=2C(=CC=CC=2)C=2NCCCN=2)=C1 USWIGGWFARNAIT-UHFFFAOYSA-N 0.000 claims description 4
IIXSESNTPZDVOB-UHFFFAOYSA-N 2-[2-[(2,6-difluorophenyl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound FC1=CC=CC(F)=C1CSC1=CC=CC=C1C1=NCCCN1 IIXSESNTPZDVOB-UHFFFAOYSA-N 0.000 claims description 4
IKNWNXHMEIPMHN-UHFFFAOYSA-N 2-[2-[(2-chloro-6-fluorophenyl)methylsulfanyl]phenyl]-3a,4,5,6,7,7a-hexahydro-1h-benzimidazole Chemical compound FC1=CC=CC(Cl)=C1CSC1=CC=CC=C1C(N1)=NC2C1CCCC2 IKNWNXHMEIPMHN-UHFFFAOYSA-N 0.000 claims description 4
HNKHRELQAZCOCP-UHFFFAOYSA-N 2-[2-[(2-chloro-6-fluorophenyl)methylsulfanyl]phenyl]-4,5-dihydro-1h-imidazole Chemical compound FC1=CC=CC(Cl)=C1CSC1=CC=CC=C1C1=NCCN1 HNKHRELQAZCOCP-UHFFFAOYSA-N 0.000 claims description 4
KTWWZGRWSAZNFV-UHFFFAOYSA-N 2-[2-[(2-methoxy-5-nitrophenyl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C([N+]([O-])=O)C=C1CSC1=CC=CC=C1C1=NCCCN1 KTWWZGRWSAZNFV-UHFFFAOYSA-N 0.000 claims description 4
YSKONJARCLBXRG-UHFFFAOYSA-N 2-[2-[(2-methoxy-5-nitrophenyl)methylsulfanyl]phenyl]-3a,4,5,6,7,7a-hexahydro-1h-benzimidazole Chemical compound COC1=CC=C([N+]([O-])=O)C=C1CSC1=CC=CC=C1C(N1)=NC2C1CCCC2 YSKONJARCLBXRG-UHFFFAOYSA-N 0.000 claims description 4
XROZEKFUKUQTAT-UHFFFAOYSA-N 2-[2-[(2-methoxy-5-nitrophenyl)methylsulfanyl]phenyl]-4,5-dihydro-1h-imidazole Chemical compound COC1=CC=C([N+]([O-])=O)C=C1CSC1=CC=CC=C1C1=NCCN1 XROZEKFUKUQTAT-UHFFFAOYSA-N 0.000 claims description 4
JURFLFGQSHDRQR-UHFFFAOYSA-N 2-[2-[(2-propan-2-yloxynaphthalen-1-yl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound CC(C)OC1=CC=C2C=CC=CC2=C1CSC1=CC=CC=C1C1=NCCCN1 JURFLFGQSHDRQR-UHFFFAOYSA-N 0.000 claims description 4
PUDQPIKMLRFZPN-UHFFFAOYSA-N 2-[2-[(5-bromo-2-cyclopentyloxyphenyl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound C=1C=CC=C(C=2NCCCN=2)C=1SCC1=CC(Br)=CC=C1OC1CCCC1 PUDQPIKMLRFZPN-UHFFFAOYSA-N 0.000 claims description 4
GPSOQGAPPIJCEG-UHFFFAOYSA-N 2-[2-[(5-bromo-2-ethoxyphenyl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound CCOC1=CC=C(Br)C=C1CSC1=CC=CC=C1C1=NCCCN1 GPSOQGAPPIJCEG-UHFFFAOYSA-N 0.000 claims description 4
CPJWCFKQCQUQLI-UHFFFAOYSA-N 2-[2-[(5-bromo-2-methoxyphenyl)methoxymethyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(Br)C=C1COCC1=CC=CC=C1C1=NCCCN1 CPJWCFKQCQUQLI-UHFFFAOYSA-N 0.000 claims description 4
RGMPFJUALNCLIZ-UHFFFAOYSA-N 2-[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]-3,4-difluorophenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(Br)C=C1CSC1=C(F)C(F)=CC=C1C1=NCCCN1 RGMPFJUALNCLIZ-UHFFFAOYSA-N 0.000 claims description 4
BHRKIYVQKAPXBH-UHFFFAOYSA-N 2-[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]-3,5-difluorophenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(Br)C=C1CSC1=C(F)C=C(F)C=C1C1=NCCCN1 BHRKIYVQKAPXBH-UHFFFAOYSA-N 0.000 claims description 4
BVRSBCUMISUFPR-UHFFFAOYSA-N 2-[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]-3-chlorophenyl]-1,4,5,6-tetrahydropyrimidin-5-ol Chemical compound COC1=CC=C(Br)C=C1CSC1=C(Cl)C=CC=C1C1=NCC(O)CN1 BVRSBCUMISUFPR-UHFFFAOYSA-N 0.000 claims description 4
ORJVHEZQRTWNPN-UHFFFAOYSA-N 2-[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]-3-chlorophenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(Br)C=C1CSC1=C(Cl)C=CC=C1C1=NCCCN1 ORJVHEZQRTWNPN-UHFFFAOYSA-N 0.000 claims description 4
LNPRXFXPBRCTGB-UHFFFAOYSA-N 2-[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]phenyl]-5-methyl-4,5-dihydro-1h-imidazole Chemical compound COC1=CC=C(Br)C=C1CSC1=CC=CC=C1C1=NC(C)CN1 LNPRXFXPBRCTGB-UHFFFAOYSA-N 0.000 claims description 4
VFXNWSNBKZPTTD-UHFFFAOYSA-N 2-[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]phenyl]guanidine Chemical compound COC1=CC=C(Br)C=C1CSC1=CC=CC=C1NC(N)=N VFXNWSNBKZPTTD-UHFFFAOYSA-N 0.000 claims description 4
DIHXBZVYCWIMIW-UHFFFAOYSA-N 2-[2-[(5-bromo-2-methoxyphenyl)sulfanylmethyl]-3-chlorophenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(Br)C=C1SCC1=C(Cl)C=CC=C1C1=NCCCN1 DIHXBZVYCWIMIW-UHFFFAOYSA-N 0.000 claims description 4
FYSBRELZWWDOLV-UHFFFAOYSA-N 2-[2-[(6-bromo-2-methoxynaphthalen-1-yl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C2C=C(Br)C=CC2=C1CSC1=CC=CC=C1C1=NCCCN1 FYSBRELZWWDOLV-UHFFFAOYSA-N 0.000 claims description 4
XZTTZBZEQYPTEC-UHFFFAOYSA-N 2-[2-[(6-methoxy-2,3-dihydro-1,4-benzodioxin-5-yl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C2OCCOC2=C1CSC1=CC=CC=C1C1=NCCCN1 XZTTZBZEQYPTEC-UHFFFAOYSA-N 0.000 claims description 4
UCANUPCLAHKJLU-UHFFFAOYSA-N 2-[2-[2-(2,3-dihydro-1,4-benzodioxin-5-yl)ethyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound C=1C=CC=2OCCOC=2C=1CCC1=CC=CC=C1C1=NCCCN1 UCANUPCLAHKJLU-UHFFFAOYSA-N 0.000 claims description 4
WMSIKZDVBSROMD-UHFFFAOYSA-N 2-[2-[2-(5-bromo-2-methoxyphenyl)ethyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(Br)C=C1CCC1=CC=CC=C1C1=NCCCN1 WMSIKZDVBSROMD-UHFFFAOYSA-N 0.000 claims description 4
SNXCNGBBNPGLHD-UHFFFAOYSA-N 2-[3-[(2-methoxynaphthalen-1-yl)sulfanylmethyl]thiophen-2-yl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C2C=CC=CC2=C1SCC=1C=CSC=1C1=NCCCN1 SNXCNGBBNPGLHD-UHFFFAOYSA-N 0.000 claims description 4
HUQNTTQVZYURMS-UHFFFAOYSA-N 2-[3-[(5-bromo-2-methoxyphenyl)methylsulfanyl]pyridin-2-yl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(Br)C=C1CSC1=CC=CN=C1C1=NCCCN1 HUQNTTQVZYURMS-UHFFFAOYSA-N 0.000 claims description 4
ONZWKMMEAIYJPY-UHFFFAOYSA-N 2-[3-fluoro-2-(2-naphthalen-1-ylethyl)phenyl]-5,5-dimethyl-1,4-dihydroimidazole Chemical compound N1C(C)(C)CN=C1C1=CC=CC(F)=C1CCC1=CC=CC2=CC=CC=C12 ONZWKMMEAIYJPY-UHFFFAOYSA-N 0.000 claims description 4
125000003006 2-dimethylaminoethyl group Chemical group [H]C([H])([H])N(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 claims description 4
YUPITEIZSJWQJT-UHFFFAOYSA-N 2-piperidin-1-ylethyl n-[2-[(2-methylnaphthalen-1-yl)methylsulfanyl]phenyl]carbamate Chemical compound CC1=CC=C2C=CC=CC2=C1CSC1=CC=CC=C1NC(=O)OCCN1CCCCC1 YUPITEIZSJWQJT-UHFFFAOYSA-N 0.000 claims description 4
QAAXFJDGBDRGRQ-UHFFFAOYSA-N 3-[4-(dimethylamino)phenyl]-1-[3-(dimethylamino)propyl]-1-(naphthalen-1-ylmethyl)thiourea Chemical compound C=1C=CC2=CC=CC=C2C=1CN(CCCN(C)C)C(=S)NC1=CC=C(N(C)C)C=C1 QAAXFJDGBDRGRQ-UHFFFAOYSA-N 0.000 claims description 4
IVLLVRGXVQYAEQ-UHFFFAOYSA-N 4-[[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]phenyl]methyl]morpholine Chemical compound COC1=CC=C(Br)C=C1CSC1=CC=CC=C1CN1CCOCC1 IVLLVRGXVQYAEQ-UHFFFAOYSA-N 0.000 claims description 4
ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 4
208000000103 Anorexia Nervosa Diseases 0.000 claims description 4
JMVNFIOCAYFCIY-UHFFFAOYSA-N [2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]phenyl]methanamine Chemical compound COC1=CC=C(Br)C=C1CSC1=CC=CC=C1CN JMVNFIOCAYFCIY-UHFFFAOYSA-N 0.000 claims description 4
JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Substances N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 claims description 4
235000010290 biphenyl Nutrition 0.000 claims description 4
239000004305 biphenyl Substances 0.000 claims description 4
YMWUJEATGCHHMB-UHFFFAOYSA-N dichloromethane Substances ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 4
RHZAFXCZRSNAJI-UHFFFAOYSA-N ethyl 4-[[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]-3-chlorophenyl]methylamino]piperidine-1-carboxylate Chemical compound C1CN(C(=O)OCC)CCC1NCC1=CC=CC(Cl)=C1SCC1=CC(Br)=CC=C1OC RHZAFXCZRSNAJI-UHFFFAOYSA-N 0.000 claims description 4
NIHNNTQXNPWCJQ-UHFFFAOYSA-N fluorene Chemical compound C1=CC=C2CC3=CC=CC=C3C2=C1 NIHNNTQXNPWCJQ-UHFFFAOYSA-N 0.000 claims description 4
125000001153 fluoro group Chemical group F* 0.000 claims description 4
125000002541 furyl group Chemical group 0.000 claims description 4
125000001041 indolyl group Chemical group 0.000 claims description 4
229910052740 iodine Inorganic materials 0.000 claims description 4
239000011630 iodine Substances 0.000 claims description 4
TWKUKZOQMKBOKB-UHFFFAOYSA-N methyl 1-(2-naphthalen-1-ylethyl)piperidine-2-carboxylate Chemical compound COC(=O)C1CCCCN1CCC1=CC=CC2=CC=CC=C12 TWKUKZOQMKBOKB-UHFFFAOYSA-N 0.000 claims description 4
SLCAGYISQJNUGD-UHFFFAOYSA-N n-[[1-(2-naphthalen-1-ylethyl)pyrrolidin-2-yl]methyl]-1h-pyrrol-2-amine Chemical compound C=1C=CC2=CC=CC=C2C=1CCN1CCCC1CNC1=CC=CN1 SLCAGYISQJNUGD-UHFFFAOYSA-N 0.000 claims description 4
CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical group C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 claims description 4
QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 4
238000002560 therapeutic procedure Methods 0.000 claims description 4
125000002813 thiocarbonyl group Chemical group *C(*)=S 0.000 claims description 4
DHMLFLUIIOQLOJ-UHFFFAOYSA-N 1,3-di(piperidin-1-yl)propan-2-yl n-(2-hexoxyphenyl)carbamate Chemical compound CCCCCCOC1=CC=CC=C1NC(=O)OC(CN1CCCCC1)CN1CCCCC1 DHMLFLUIIOQLOJ-UHFFFAOYSA-N 0.000 claims description 3
RGFBAGOHQXOXRY-UHFFFAOYSA-N 1,3-di(piperidin-1-yl)propan-2-yl n-[2-(naphthalen-1-ylmethylsulfanyl)phenyl]carbamate Chemical compound C=1C=CC=C(SCC=2C3=CC=CC=C3C=CC=2)C=1NC(=O)OC(CN1CCCCC1)CN1CCCCC1 RGFBAGOHQXOXRY-UHFFFAOYSA-N 0.000 claims description 3
GAZFMSFTOKVZQL-UHFFFAOYSA-N 1-(1-ethylpyrrolidin-2-yl)-n-(naphthalen-1-ylmethyl)-n-(naphthalen-2-ylmethyl)methanamine Chemical compound CCN1CCCC1CN(CC=1C2=CC=CC=C2C=CC=1)CC1=CC=C(C=CC=C2)C2=C1 GAZFMSFTOKVZQL-UHFFFAOYSA-N 0.000 claims description 3
QCIYTUBLCHCWKF-UHFFFAOYSA-N 1-[3-[(5-bromo-2-methoxyphenyl)methylsulfanyl]pyrazin-2-yl]pyrrolidin-3-amine Chemical compound COC1=CC=C(Br)C=C1CSC1=NC=CN=C1N1CC(N)CC1 QCIYTUBLCHCWKF-UHFFFAOYSA-N 0.000 claims description 3
WODPAVGRLDMTGA-UHFFFAOYSA-N 1-[[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]-3-chlorophenyl]methyl]-2-(methoxymethyl)pyrrolidine Chemical compound COCC1CCCN1CC1=CC=CC(Cl)=C1SCC1=CC(Br)=CC=C1OC WODPAVGRLDMTGA-UHFFFAOYSA-N 0.000 claims description 3
JMUUYBCFUZIXOY-UHFFFAOYSA-N 1-[[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]-3-chlorophenyl]methyl]azetidine Chemical compound COC1=CC=C(Br)C=C1CSC1=C(Cl)C=CC=C1CN1CCC1 JMUUYBCFUZIXOY-UHFFFAOYSA-N 0.000 claims description 3
NDPLIKQZAAIEAD-UHFFFAOYSA-N 1-[[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]-3-chlorophenyl]methyl]piperazine Chemical compound COC1=CC=C(Br)C=C1CSC1=C(Cl)C=CC=C1CN1CCNCC1 NDPLIKQZAAIEAD-UHFFFAOYSA-N 0.000 claims description 3
AWVJYNDPVRJZQI-UHFFFAOYSA-N 1-[[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]-3-chlorophenyl]methyl]pyrrolidin-3-amine Chemical compound COC1=CC=C(Br)C=C1CSC1=C(Cl)C=CC=C1CN1CC(N)CC1 AWVJYNDPVRJZQI-UHFFFAOYSA-N 0.000 claims description 3
IFCDMRMMCXRJEV-UHFFFAOYSA-N 1-[[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]-3-chlorophenyl]methyl]pyrrolidin-3-ol Chemical compound COC1=CC=C(Br)C=C1CSC1=C(Cl)C=CC=C1CN1CC(O)CC1 IFCDMRMMCXRJEV-UHFFFAOYSA-N 0.000 claims description 3
IKYPYTQRZDPPLI-UHFFFAOYSA-N 1-[[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]phenyl]methyl]pyrrolidin-3-amine Chemical compound COC1=CC=C(Br)C=C1CSC1=CC=CC=C1CN1CC(N)CC1 IKYPYTQRZDPPLI-UHFFFAOYSA-N 0.000 claims description 3
WOAQXXVCKUXXIM-UHFFFAOYSA-N 1-[[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]phenyl]methyl]pyrrolidin-3-ol Chemical compound COC1=CC=C(Br)C=C1CSC1=CC=CC=C1CN1CC(O)CC1 WOAQXXVCKUXXIM-UHFFFAOYSA-N 0.000 claims description 3
LPFIAUCSSYOSJI-UHFFFAOYSA-N 2-(2-benzhydrylsulfanylphenyl)-1,4,5,6-tetrahydropyrimidine Chemical compound C1CCNC(C=2C(=CC=CC=2)SC(C=2C=CC=CC=2)C=2C=CC=CC=2)=N1 LPFIAUCSSYOSJI-UHFFFAOYSA-N 0.000 claims description 3
DLZFOGIKAJESJI-UHFFFAOYSA-N 2-[2-(1-naphthalen-1-ylethylsulfanyl)phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound C=1C=CC2=CC=CC=C2C=1C(C)SC1=CC=CC=C1C1=NCCCN1 DLZFOGIKAJESJI-UHFFFAOYSA-N 0.000 claims description 3
FWPVLIBLPJCPKP-UHFFFAOYSA-N 2-[2-(2,3-dihydro-1,4-benzodioxin-5-ylmethylsulfanyl)phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound C=1C=CC=2OCCOC=2C=1CSC1=CC=CC=C1C1=NCCCN1 FWPVLIBLPJCPKP-UHFFFAOYSA-N 0.000 claims description 3
HLXFXORVYDASPB-UHFFFAOYSA-N 2-[2-(cyclohexylmethylsulfanyl)phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound C1CCCCC1CSC1=CC=CC=C1C1=NCCCN1 HLXFXORVYDASPB-UHFFFAOYSA-N 0.000 claims description 3
QDZMJIFWBKCDIU-UHFFFAOYSA-N 2-[2-(naphthalen-1-ylmethoxy)phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound C=1C=CC2=CC=CC=C2C=1COC1=CC=CC=C1C1=NCCCN1 QDZMJIFWBKCDIU-UHFFFAOYSA-N 0.000 claims description 3
WUXIBNPXDCPMEH-UHFFFAOYSA-N 2-[2-(naphthalen-1-ylmethylsulfanyl)phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound C=1C=CC2=CC=CC=C2C=1CSC1=CC=CC=C1C1=NCCCN1 WUXIBNPXDCPMEH-UHFFFAOYSA-N 0.000 claims description 3
FIZAQPWFWADZQW-UHFFFAOYSA-N 2-[2-(naphthalen-1-ylsulfanylmethyl)phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound C=1C=CC2=CC=CC=C2C=1SCC1=CC=CC=C1C1=NCCCN1 FIZAQPWFWADZQW-UHFFFAOYSA-N 0.000 claims description 3
PTYYJYFKWLYTJJ-UHFFFAOYSA-N 2-[2-(naphthalen-1-ylsulfanylmethyl)phenyl]-4,5-dihydro-1h-imidazole Chemical compound C=1C=CC2=CC=CC=C2C=1SCC1=CC=CC=C1C1=NCCN1 PTYYJYFKWLYTJJ-UHFFFAOYSA-N 0.000 claims description 3
WWNCZFPVXCKTNW-UHFFFAOYSA-N 2-[2-[(2,5-dimethoxyphenyl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(OC)C(CSC=2C(=CC=CC=2)C=2NCCCN=2)=C1 WWNCZFPVXCKTNW-UHFFFAOYSA-N 0.000 claims description 3
SUSFCKRSJXFKFJ-UHFFFAOYSA-N 2-[2-[(2,5-dimethoxyphenyl)sulfanylmethyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(OC)C(SCC=2C(=CC=CC=2)C=2NCCCN=2)=C1 SUSFCKRSJXFKFJ-UHFFFAOYSA-N 0.000 claims description 3
JCBIOHYTOHEEKN-UHFFFAOYSA-N 2-[2-[(2-chlorophenyl)sulfanylmethyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound ClC1=CC=CC=C1SCC1=CC=CC=C1C1=NCCCN1 JCBIOHYTOHEEKN-UHFFFAOYSA-N 0.000 claims description 3
UEYAWOPDBOWKEK-UHFFFAOYSA-N 2-[2-[(2-fluorophenyl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound FC1=CC=CC=C1CSC1=CC=CC=C1C1=NCCCN1 UEYAWOPDBOWKEK-UHFFFAOYSA-N 0.000 claims description 3
JLIDYMPVMLNLGY-UHFFFAOYSA-N 2-[2-[(2-methoxy-5-nitrophenyl)methylsulfanyl]pyridin-3-yl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C([N+]([O-])=O)C=C1CSC1=NC=CC=C1C1=NCCCN1 JLIDYMPVMLNLGY-UHFFFAOYSA-N 0.000 claims description 3
QRISVWPWDXQJMG-UHFFFAOYSA-N 2-[2-[(2-methoxyphenyl)sulfanylmethyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=CC=C1SCC1=CC=CC=C1C1=NCCCN1 QRISVWPWDXQJMG-UHFFFAOYSA-N 0.000 claims description 3
YZQSLUVOBLBNMG-UHFFFAOYSA-N 2-[2-[(3,5-dimethoxyphenyl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC(OC)=CC(CSC=2C(=CC=CC=2)C=2NCCCN=2)=C1 YZQSLUVOBLBNMG-UHFFFAOYSA-N 0.000 claims description 3
YQXGBUCFRQYHMD-UHFFFAOYSA-N 2-[2-[(3-methoxyphenyl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=CC(CSC=2C(=CC=CC=2)C=2NCCCN=2)=C1 YQXGBUCFRQYHMD-UHFFFAOYSA-N 0.000 claims description 3
KWBUUMUFWHBVGS-UHFFFAOYSA-N 2-[2-[(4-fluorophenyl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound C1=CC(F)=CC=C1CSC1=CC=CC=C1C1=NCCCN1 KWBUUMUFWHBVGS-UHFFFAOYSA-N 0.000 claims description 3
DRCKIXIPSQZHTF-UHFFFAOYSA-N 2-[2-[(4-phenylmethoxyphenyl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound C=1C=CC=CC=1COC(C=C1)=CC=C1CSC1=CC=CC=C1C1=NCCCN1 DRCKIXIPSQZHTF-UHFFFAOYSA-N 0.000 claims description 3
DHGHRXKJJOANFR-UHFFFAOYSA-N 2-[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]-3-chlorophenyl]-5-methyl-4,5-dihydro-1h-imidazole Chemical compound COC1=CC=C(Br)C=C1CSC1=C(Cl)C=CC=C1C1=NC(C)CN1 DHGHRXKJJOANFR-UHFFFAOYSA-N 0.000 claims description 3
WHXSLNWBYOEZBI-UHFFFAOYSA-N 2-[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]-3-fluoro-4-(trifluoromethyl)phenyl]-5,5-dimethyl-1,4-dihydroimidazole Chemical compound COC1=CC=C(Br)C=C1CSC1=C(F)C(C(F)(F)F)=CC=C1C1=NC(C)(C)CN1 WHXSLNWBYOEZBI-UHFFFAOYSA-N 0.000 claims description 3
QMSDCVRXVFCLRL-UHFFFAOYSA-N 2-[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(Br)C=C1CSC1=CC=CC=C1C1=NCCCN1 QMSDCVRXVFCLRL-UHFFFAOYSA-N 0.000 claims description 3
CXKQSXANCQVLRO-UHFFFAOYSA-N 2-[2-[(5-bromo-2-methoxyphenyl)sulfanylmethyl]-3-fluorophenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(Br)C=C1SCC1=C(F)C=CC=C1C1=NCCCN1 CXKQSXANCQVLRO-UHFFFAOYSA-N 0.000 claims description 3
DSRUBXVCPSJSAX-UHFFFAOYSA-N 2-[2-[2-(2-methylnaphthalen-1-yl)ethyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound CC1=CC=C2C=CC=CC2=C1CCC1=CC=CC=C1C1=NCCCN1 DSRUBXVCPSJSAX-UHFFFAOYSA-N 0.000 claims description 3
XFWBPYOQWBEJDY-UHFFFAOYSA-N 2-[3-chloro-2-(2-naphthalen-1-ylethyl)phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound C=1C=CC2=CC=CC=C2C=1CCC=1C(Cl)=CC=CC=1C1=NCCCN1 XFWBPYOQWBEJDY-UHFFFAOYSA-N 0.000 claims description 3
VQPNUOOVVQVJAQ-UHFFFAOYSA-N 2-[3-fluoro-2-(2-naphthalen-1-ylethyl)phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound C=1C=CC2=CC=CC=C2C=1CCC=1C(F)=CC=CC=1C1=NCCCN1 VQPNUOOVVQVJAQ-UHFFFAOYSA-N 0.000 claims description 3
WWQPTDNNDBFOLF-UHFFFAOYSA-N 2-[3-methoxy-2-(2-naphthalen-1-ylethyl)phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound C=1C=CC2=CC=CC=C2C=1CCC=1C(OC)=CC=CC=1C1=NCCCN1 WWQPTDNNDBFOLF-UHFFFAOYSA-N 0.000 claims description 3
REYLZFXVSGOFRG-UHFFFAOYSA-N 2-[4-(naphthalen-1-ylmethylsulfanyl)phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound C=1C=CC2=CC=CC=C2C=1CSC(C=C1)=CC=C1C1=NCCCN1 REYLZFXVSGOFRG-UHFFFAOYSA-N 0.000 claims description 3
HLMAGOZCRZZHQE-UHFFFAOYSA-N 3-imidazol-1-yl-n-(naphthalen-1-ylmethyl)-n-(naphthalen-2-ylmethyl)propan-1-amine Chemical compound C=1C=C2C=CC=CC2=CC=1CN(CC=1C2=CC=CC=C2C=CC=1)CCCN1C=CN=C1 HLMAGOZCRZZHQE-UHFFFAOYSA-N 0.000 claims description 3
XWXDYXQSASHOQE-UHFFFAOYSA-N 4-methoxy-3-[[2-(1,4,5,6-tetrahydropyrimidin-2-yl)phenyl]sulfanylmethyl]benzonitrile Chemical compound COC1=CC=C(C#N)C=C1CSC1=CC=CC=C1C1=NCCCN1 XWXDYXQSASHOQE-UHFFFAOYSA-N 0.000 claims description 3
229940126661 MC4 antagonist Drugs 0.000 claims description 3
241000051616 Ulmus minor Species 0.000 claims description 3
DBIZGVXQPFDTDA-UHFFFAOYSA-N [1-[[2-(2-naphthalen-1-ylethyl)phenyl]methyl]piperidin-2-yl]methanol Chemical compound OCC1CCCCN1CC1=CC=CC=C1CCC1=CC=CC2=CC=CC=C12 DBIZGVXQPFDTDA-UHFFFAOYSA-N 0.000 claims description 3
125000005157 alkyl carboxy group Chemical group 0.000 claims description 3
125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 claims description 3
125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 claims description 3
125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 claims description 3
125000001887 cyclopentyloxy group Chemical group C1(CCCC1)O* 0.000 claims description 3
125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 claims description 3
WHPBDZMNGAVUPV-UHFFFAOYSA-N n-[(3-bromophenyl)methyl]-1-(1-ethylpyrrolidin-2-yl)-n-(naphthalen-1-ylmethyl)methanamine Chemical compound CCN1CCCC1CN(CC=1C2=CC=CC=C2C=CC=1)CC1=CC=CC(Br)=C1 WHPBDZMNGAVUPV-UHFFFAOYSA-N 0.000 claims description 3
RTHMKHFTQFJYGA-UHFFFAOYSA-N n-[(5-bromo-2-methoxyphenyl)methyl]-n-methyl-2-(1,4,5,6-tetrahydropyrimidin-2-yl)aniline Chemical compound COC1=CC=C(Br)C=C1CN(C)C1=CC=CC=C1C1=NCCCN1 RTHMKHFTQFJYGA-UHFFFAOYSA-N 0.000 claims description 3
IUUWYNSTWKOEJX-UHFFFAOYSA-N n-[2-(dimethylamino)ethyl]-n-(naphthalen-1-ylmethyl)naphthalene-2-sulfonamide Chemical compound C1=CC=CC2=CC(S(=O)(=O)N(CC=3C4=CC=CC=C4C=CC=3)CCN(C)C)=CC=C21 IUUWYNSTWKOEJX-UHFFFAOYSA-N 0.000 claims description 3
125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 claims description 3
125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 claims description 3
125000003003 spiro group Chemical group 0.000 claims description 3
125000005015 aryl alkynyl group Chemical group 0.000 claims description 2
125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 claims description 2
125000001309 chloro group Chemical group Cl* 0.000 claims description 2
WCDWBPCFGJXFJZ-UHFFFAOYSA-N etanidazole Chemical group OCCNC(=O)CN1C=CN=C1[N+]([O-])=O WCDWBPCFGJXFJZ-UHFFFAOYSA-N 0.000 claims description 2
238000006467 substitution reaction Methods 0.000 claims description 2
125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims 5
ANFXTILBDGTSEG-UHFFFAOYSA-N 1-methyl-4,5-dihydroimidazole Chemical group CN1CCN=C1 ANFXTILBDGTSEG-UHFFFAOYSA-N 0.000 claims 2
SMTXSQTYIZFVIR-UHFFFAOYSA-N 2-[2-[(2-cyclopentyloxynaphthalen-1-yl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound C1CCCC1OC=1C=CC2=CC=CC=C2C=1CSC1=CC=CC=C1C1=NCCCN1 SMTXSQTYIZFVIR-UHFFFAOYSA-N 0.000 claims 2
IZUJSZAYULSQCW-UHFFFAOYSA-N 2-[2-[(2-iodophenyl)methylsulfanyl]phenyl]-3a,4,5,6,7,7a-hexahydro-1h-benzimidazole Chemical compound IC1=CC=CC=C1CSC1=CC=CC=C1C(N1)=NC2C1CCCC2 IZUJSZAYULSQCW-UHFFFAOYSA-N 0.000 claims 2
VUQUNQSDLBZMCT-UHFFFAOYSA-N 2-[2-[(2-methoxyphenyl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=CC=C1CSC1=CC=CC=C1C1=NCCCN1 VUQUNQSDLBZMCT-UHFFFAOYSA-N 0.000 claims 2
UPQADLLHDZSLHC-UHFFFAOYSA-N CC(C=C1)=CC(CSC(C=CC=C2)=C2N2C=NCCC2)=C1OC Chemical compound CC(C=C1)=CC(CSC(C=CC=C2)=C2N2C=NCCC2)=C1OC UPQADLLHDZSLHC-UHFFFAOYSA-N 0.000 claims 2
QIJLUZAUEGPNIB-UHFFFAOYSA-N n'-[(5-bromo-2-methoxyphenyl)methyl]-n,n-dimethyl-n'-(naphthalen-1-ylmethyl)propane-1,3-diamine Chemical compound COC1=CC=C(Br)C=C1CN(CCCN(C)C)CC1=CC=CC2=CC=CC=C12 QIJLUZAUEGPNIB-UHFFFAOYSA-N 0.000 claims 2
AZJXYSILXBMBDR-UHFFFAOYSA-N n,n-dimethyl-n'-(naphthalen-1-ylmethyl)-n'-(naphthalen-2-ylmethyl)propane-1,3-diamine Chemical compound C1=CC=C2C(CN(CC=3C=C4C=CC=CC4=CC=3)CCCN(C)C)=CC=CC2=C1 AZJXYSILXBMBDR-UHFFFAOYSA-N 0.000 claims 2
125000000027 (C1-C10) alkoxy group Chemical group 0.000 claims 1
FGYBDASKYMSNCX-UHFFFAOYSA-N 2,5-dichlorothiophene Chemical compound ClC1=CC=C(Cl)S1 FGYBDASKYMSNCX-UHFFFAOYSA-N 0.000 claims 1
125000006508 2,6-difluorobenzyl group Chemical group [H]C1=C([H])C(F)=C(C(F)=C1[H])C([H])([H])* 0.000 claims 1
HFYUGPNUTBOKQF-UHFFFAOYSA-N 6-piperazin-1-yl-7-(trifluoromethyl)thieno[3,2-b]pyridine-3-carboxylic acid Chemical compound C=1N=C2C(C(=O)O)=CSC2=C(C(F)(F)F)C=1N1CCNCC1 HFYUGPNUTBOKQF-UHFFFAOYSA-N 0.000 claims 1
102100022404 E3 ubiquitin-protein ligase Midline-1 Human genes 0.000 claims 1
101710102210 E3 ubiquitin-protein ligase Midline-1 Proteins 0.000 claims 1
230000021615 conjugation Effects 0.000 claims 1
CBHCDHNUZWWAPP-UHFFFAOYSA-N pecazine Chemical compound C1N(C)CCCC1CN1C2=CC=CC=C2SC2=CC=CC=C21 CBHCDHNUZWWAPP-UHFFFAOYSA-N 0.000 claims 1
229950007538 pecazine Drugs 0.000 claims 1
150000003230 pyrimidines Chemical class 0.000 claims 1
150000005326 tetrahydropyrimidines Chemical class 0.000 claims 1
125000004001 thioalkyl group Chemical group 0.000 claims 1
239000000126 substance Substances 0.000 abstract description 16
201000010099 disease Diseases 0.000 abstract description 8
102000008316 Type 4 Melanocortin Receptor Human genes 0.000 description 242
210000004027 cell Anatomy 0.000 description 36
125000003282 alkyl amino group Chemical group 0.000 description 30
125000001769 aryl amino group Chemical group 0.000 description 26
229910019142 PO4 Inorganic materials 0.000 description 24
125000004442 acylamino group Chemical group 0.000 description 24
125000004414 alkyl thio group Chemical group 0.000 description 24
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 24
239000010452 phosphate Substances 0.000 description 24
BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 24
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 23
125000004453 alkoxycarbonyl group Chemical group 0.000 description 23
235000019000 fluorine Nutrition 0.000 description 23
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 22
125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 description 22
125000005110 aryl thio group Chemical group 0.000 description 22
235000017168 chlorine Nutrition 0.000 description 22
230000000694 effects Effects 0.000 description 22
UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 description 22
125000004947 alkyl aryl amino group Chemical group 0.000 description 21
125000004986 diarylamino group Chemical group 0.000 description 21
125000003806 alkyl carbonyl amino group Chemical group 0.000 description 20
125000004691 alkyl thio carbonyl group Chemical group 0.000 description 20
ACVYVLVWPXVTIT-UHFFFAOYSA-M phosphinate Chemical compound [O-][PH2]=O ACVYVLVWPXVTIT-UHFFFAOYSA-M 0.000 description 20
125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 20
125000004658 aryl carbonyl amino group Chemical group 0.000 description 19
125000001951 carbamoylamino group Chemical group C(N)(=O)N* 0.000 description 19
239000000243 solution Substances 0.000 description 19
125000005199 aryl carbonyloxy group Chemical group 0.000 description 18
125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 18
125000005196 alkyl carbonyloxy group Chemical group 0.000 description 17
150000007942 carboxylates Chemical class 0.000 description 17
125000005200 aryloxy carbonyloxy group Chemical group 0.000 description 16
PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 16
230000006870 function Effects 0.000 description 15
102000005962 receptors Human genes 0.000 description 15
108020003175 receptors Proteins 0.000 description 15
125000005194 alkoxycarbonyloxy group Chemical group 0.000 description 14
239000012528 membrane Substances 0.000 description 14
229940124530 sulfonamide Drugs 0.000 description 14
150000003456 sulfonamides Chemical class 0.000 description 14
229940079593 drug Drugs 0.000 description 13
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
125000002877 alkyl aryl group Chemical group 0.000 description 12
150000001540 azides Chemical class 0.000 description 12
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
239000004480 active ingredient Substances 0.000 description 11
238000009472 formulation Methods 0.000 description 11
238000002821 scintillation proximity assay Methods 0.000 description 11
238000012360 testing method Methods 0.000 description 11
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 10
108010008364 Melanocortins Proteins 0.000 description 10
102100027467 Pro-opiomelanocortin Human genes 0.000 description 10
KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 10
YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 10
125000005129 aryl carbonyl group Chemical group 0.000 description 10
239000007924 injection Substances 0.000 description 10
238000002347 injection Methods 0.000 description 10
239000003446 ligand Substances 0.000 description 10
239000000047 product Substances 0.000 description 10
150000003573 thiols Chemical class 0.000 description 10
102000004378 Melanocortin Receptors Human genes 0.000 description 9
108090000950 Melanocortin Receptors Proteins 0.000 description 9
235000019441 ethanol Nutrition 0.000 description 9
230000003993 interaction Effects 0.000 description 9
229960005141 piperazine Drugs 0.000 description 9
YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 8
KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 description 8
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 8
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 8
229930006000 Sucrose Natural products 0.000 description 8
125000004457 alkyl amino carbonyl group Chemical group 0.000 description 8
230000015572 biosynthetic process Effects 0.000 description 8
150000002430 hydrocarbons Chemical group 0.000 description 8
239000000546 pharmaceutical excipient Substances 0.000 description 8
239000000843 powder Substances 0.000 description 8
229960004793 sucrose Drugs 0.000 description 8
239000000725 suspension Substances 0.000 description 8
238000003786 synthesis reaction Methods 0.000 description 8
239000003826 tablet Substances 0.000 description 8
XFNJVJPLKCPIBV-UHFFFAOYSA-N trimethylenediamine Chemical compound NCCCN XFNJVJPLKCPIBV-UHFFFAOYSA-N 0.000 description 8
238000010521 absorption reaction Methods 0.000 description 7
239000002585 base Substances 0.000 description 7
KWEDUNSJJZVRKR-UHFFFAOYSA-N carbononitridic azide Chemical compound [N-]=[N+]=NC#N KWEDUNSJJZVRKR-UHFFFAOYSA-N 0.000 description 7
150000002431 hydrogen Chemical class 0.000 description 7
239000002865 melanocortin Substances 0.000 description 7
125000002757 morpholinyl group Chemical group 0.000 description 7
125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 7
229920001223 polyethylene glycol Polymers 0.000 description 7
239000005720 sucrose Substances 0.000 description 7
RFFLAFLAYFXFSW-UHFFFAOYSA-N 1,2-dichlorobenzene Chemical compound ClC1=CC=CC=C1Cl RFFLAFLAYFXFSW-UHFFFAOYSA-N 0.000 description 6
RGSFGYAAUTVSQA-UHFFFAOYSA-N Cyclopentane Chemical compound C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 6
102100023723 Melanocortin receptor 5 Human genes 0.000 description 6
101710085771 Melanocortin receptor 5 Proteins 0.000 description 6
241000699666 Mus <mouse, genus> Species 0.000 description 6
241000699670 Mus sp. Species 0.000 description 6
239000002202 Polyethylene glycol Substances 0.000 description 6
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
229920002472 Starch Polymers 0.000 description 6
HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 6
150000001412 amines Chemical class 0.000 description 6
IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical compound C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 6
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
125000000392 cycloalkenyl group Chemical group 0.000 description 6
239000002552 dosage form Substances 0.000 description 6
125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 6
239000007788 liquid Substances 0.000 description 6
VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
239000002904 solvent Substances 0.000 description 6
239000008107 starch Substances 0.000 description 6
235000019698 starch Nutrition 0.000 description 6
239000000829 suppository Substances 0.000 description 6
WHNFPRLDDSXQCL-UAZQEYIDSA-N α-msh Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(N)=O)NC(=O)[C@H](CO)NC(C)=O)C1=CC=C(O)C=C1 WHNFPRLDDSXQCL-UAZQEYIDSA-N 0.000 description 6
CNIIGCLFLJGOGP-UHFFFAOYSA-N 2-(1-naphthalenylmethyl)-4,5-dihydro-1H-imidazole Chemical compound C=1C=CC2=CC=CC=C2C=1CC1=NCCN1 CNIIGCLFLJGOGP-UHFFFAOYSA-N 0.000 description 5
GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 5
108010010803 Gelatin Proteins 0.000 description 5
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 5
102100034216 Melanocyte-stimulating hormone receptor Human genes 0.000 description 5
101710161100 Melanocyte-stimulating hormone receptor Proteins 0.000 description 5
241001024304 Mino Species 0.000 description 5
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 5
125000004644 alkyl sulfinyl group Chemical group 0.000 description 5
239000003963 antioxidant agent Substances 0.000 description 5
235000006708 antioxidants Nutrition 0.000 description 5
125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 5
239000002775 capsule Substances 0.000 description 5
238000006243 chemical reaction Methods 0.000 description 5
238000000576 coating method Methods 0.000 description 5
239000000499 gel Substances 0.000 description 5
229920000159 gelatin Polymers 0.000 description 5
239000008273 gelatin Substances 0.000 description 5
235000019322 gelatine Nutrition 0.000 description 5
235000011852 gelatine desserts Nutrition 0.000 description 5
230000006698 induction Effects 0.000 description 5
239000008101 lactose Substances 0.000 description 5
239000002674 ointment Substances 0.000 description 5
229910052698 phosphorus Inorganic materials 0.000 description 5
239000006187 pill Substances 0.000 description 5
239000003755 preservative agent Substances 0.000 description 5
239000007787 solid Substances 0.000 description 5
NQRYJNQNLNOLGT-UHFFFAOYSA-N tetrahydropyridine hydrochloride Natural products C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 5
FCEHBMOGCRZNNI-UHFFFAOYSA-N 1-benzothiophene Chemical compound C1=CC=C2SC=CC2=C1 FCEHBMOGCRZNNI-UHFFFAOYSA-N 0.000 description 4
IGCCPAKERWHUNZ-UHFFFAOYSA-N 2-[2-[(5-bromo-2-methoxyphenyl)sulfanylmethyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(Br)C=C1SCC1=CC=CC=C1C1=NCCCN1 IGCCPAKERWHUNZ-UHFFFAOYSA-N 0.000 description 4
102100022455 Adrenocorticotropic hormone receptor Human genes 0.000 description 4
241000416162 Astragalus gummifer Species 0.000 description 4
101800000414 Corticotropin Proteins 0.000 description 4
SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 4
101800001751 Melanocyte-stimulating hormone alpha Proteins 0.000 description 4
241001465754 Metazoa Species 0.000 description 4
YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 4
PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 4
XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 4
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 4
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
229920001615 Tragacanth Polymers 0.000 description 4
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
230000005856 abnormality Effects 0.000 description 4
125000005090 alkenylcarbonyl group Chemical group 0.000 description 4
125000004682 aminothiocarbonyl group Chemical group NC(=S)* 0.000 description 4
MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Chemical compound C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 description 4
238000003556 assay Methods 0.000 description 4
239000011324 bead Substances 0.000 description 4
239000000872 buffer Substances 0.000 description 4
IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 description 4
229960000258 corticotropin Drugs 0.000 description 4
125000004473 dialkylaminocarbonyl group Chemical group 0.000 description 4
235000011187 glycerol Nutrition 0.000 description 4
238000001727 in vivo Methods 0.000 description 4
230000001965 increasing effect Effects 0.000 description 4
238000001802 infusion Methods 0.000 description 4
AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 4
239000000463 material Substances 0.000 description 4
APVPOHHVBBYQAV-UHFFFAOYSA-N n-(4-aminophenyl)sulfonyloctadecanamide Chemical compound CCCCCCCCCCCCCCCCCC(=O)NS(=O)(=O)C1=CC=C(N)C=C1 APVPOHHVBBYQAV-UHFFFAOYSA-N 0.000 description 4
108090000623 proteins and genes Proteins 0.000 description 4
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 4
XSCHRSMBECNVNS-UHFFFAOYSA-N quinoxaline Chemical compound N1=CC=NC2=CC=CC=C21 XSCHRSMBECNVNS-UHFFFAOYSA-N 0.000 description 4
239000011734 sodium Substances 0.000 description 4
239000007921 spray Substances 0.000 description 4
238000003756 stirring Methods 0.000 description 4
238000007920 subcutaneous administration Methods 0.000 description 4
239000000454 talc Substances 0.000 description 4
235000012222 talc Nutrition 0.000 description 4
229910052623 talc Inorganic materials 0.000 description 4
125000005300 thiocarboxy group Chemical group C(=S)(O)* 0.000 description 4
RMVRSNDYEFQCLF-UHFFFAOYSA-N thiophenol Chemical compound SC1=CC=CC=C1 RMVRSNDYEFQCLF-UHFFFAOYSA-N 0.000 description 4
235000010487 tragacanth Nutrition 0.000 description 4
239000000196 tragacanth Substances 0.000 description 4
229940116362 tragacanth Drugs 0.000 description 4
239000003981 vehicle Substances 0.000 description 4
239000000080 wetting agent Substances 0.000 description 4
YXBXWTPGDOGXMJ-UHFFFAOYSA-N (2-hexoxyphenyl)carbamic acid Chemical compound CCCCCCOC1=CC=CC=C1NC(O)=O YXBXWTPGDOGXMJ-UHFFFAOYSA-N 0.000 description 3
OTPDWCMLUKMQNO-UHFFFAOYSA-N 1,2,3,4-tetrahydropyrimidine Chemical group C1NCC=CN1 OTPDWCMLUKMQNO-UHFFFAOYSA-N 0.000 description 3
HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 3
229920001817 Agar Polymers 0.000 description 3
239000000055 Corticotropin-Releasing Hormone Substances 0.000 description 3
XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 3
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
108091006027 G proteins Proteins 0.000 description 3
102000030782 GTP binding Human genes 0.000 description 3
108091000058 GTP-Binding Proteins 0.000 description 3
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
102100023726 Melanocortin receptor 3 Human genes 0.000 description 3
101710085774 Melanocortin receptor 3 Proteins 0.000 description 3
102400000747 Melanocyte-stimulating hormone beta Human genes 0.000 description 3
101710129905 Melanotropin beta Proteins 0.000 description 3
241001553014 Myrsine salicina Species 0.000 description 3
208000008589 Obesity Diseases 0.000 description 3
OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 3
230000002159 abnormal effect Effects 0.000 description 3
230000004913 activation Effects 0.000 description 3
102000030621 adenylate cyclase Human genes 0.000 description 3
108060000200 adenylate cyclase Proteins 0.000 description 3
239000008272 agar Substances 0.000 description 3
235000010419 agar Nutrition 0.000 description 3
230000032683 aging Effects 0.000 description 3
235000010443 alginic acid Nutrition 0.000 description 3
229920000615 alginic acid Polymers 0.000 description 3
125000002723 alicyclic group Chemical group 0.000 description 3
125000005089 alkenylaminocarbonyl group Chemical group 0.000 description 3
150000001408 amides Chemical class 0.000 description 3
150000001413 amino acids Chemical group 0.000 description 3
150000008064 anhydrides Chemical class 0.000 description 3
125000005125 aryl alkyl amino carbonyl group Chemical group 0.000 description 3
210000004556 brain Anatomy 0.000 description 3
239000012267 brine Substances 0.000 description 3
125000004369 butenyl group Chemical group C(=CCC)* 0.000 description 3
239000000969 carrier Substances 0.000 description 3
210000000170 cell membrane Anatomy 0.000 description 3
235000010980 cellulose Nutrition 0.000 description 3
229920002678 cellulose Polymers 0.000 description 3
239000001913 cellulose Substances 0.000 description 3
210000003169 central nervous system Anatomy 0.000 description 3
239000003245 coal Substances 0.000 description 3
239000011248 coating agent Substances 0.000 description 3
235000005687 corn oil Nutrition 0.000 description 3
239000002285 corn oil Substances 0.000 description 3
239000006071 cream Substances 0.000 description 3
239000002270 dispersing agent Substances 0.000 description 3
239000003995 emulsifying agent Substances 0.000 description 3
125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 3
239000007789 gas Substances 0.000 description 3
239000008187 granular material Substances 0.000 description 3
DMEGYFMYUHOHGS-UHFFFAOYSA-N heptamethylene Natural products C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 description 3
238000011065 in-situ storage Methods 0.000 description 3
239000003701 inert diluent Substances 0.000 description 3
239000004615 ingredient Substances 0.000 description 3
238000001990 intravenous administration Methods 0.000 description 3
239000000314 lubricant Substances 0.000 description 3
239000002609 medium Substances 0.000 description 3
230000035772 mutation Effects 0.000 description 3
235000020824 obesity Nutrition 0.000 description 3
239000003921 oil Substances 0.000 description 3
235000019198 oils Nutrition 0.000 description 3
239000004006 olive oil Substances 0.000 description 3
235000008390 olive oil Nutrition 0.000 description 3
150000007524 organic acids Chemical class 0.000 description 3
238000007911 parenteral administration Methods 0.000 description 3
239000008188 pellet Substances 0.000 description 3
239000000825 pharmaceutical preparation Substances 0.000 description 3
125000004437 phosphorous atom Chemical group 0.000 description 3
239000011574 phosphorus Substances 0.000 description 3
229920000642 polymer Polymers 0.000 description 3
238000002360 preparation method Methods 0.000 description 3
239000003380 propellant Substances 0.000 description 3
125000004368 propenyl group Chemical group C(=CC)* 0.000 description 3
238000000159 protein binding assay Methods 0.000 description 3
238000000746 purification Methods 0.000 description 3
PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical compound C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 description 3
239000002287 radioligand Substances 0.000 description 3
230000009467 reduction Effects 0.000 description 3
230000004044 response Effects 0.000 description 3
230000001568 sexual effect Effects 0.000 description 3
HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 3
239000006228 supernatant Substances 0.000 description 3
208000024891 symptom Diseases 0.000 description 3
CXWXQJXEFPUFDZ-UHFFFAOYSA-N tetralin Chemical compound C1=CC=C2CCCCC2=C1 CXWXQJXEFPUFDZ-UHFFFAOYSA-N 0.000 description 3
230000001225 therapeutic effect Effects 0.000 description 3
229930192474 thiophene Natural products 0.000 description 3
JIVZKJJQOZQXQB-UHFFFAOYSA-N tolazoline Chemical compound C=1C=CC=CC=1CC1=NCCN1 JIVZKJJQOZQXQB-UHFFFAOYSA-N 0.000 description 3
230000000699 topical effect Effects 0.000 description 3
150000003852 triazoles Chemical class 0.000 description 3
125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 description 3
125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 3
239000001993 wax Substances 0.000 description 3
230000004584 weight gain Effects 0.000 description 3
235000019786 weight gain Nutrition 0.000 description 3
SFVVQRJOGUKCEG-OPQSFPLASA-N β-MSH Chemical compound C1C[C@@H](O)[C@H]2C(COC(=O)[C@@](O)([C@@H](C)O)C(C)C)=CCN21 SFVVQRJOGUKCEG-OPQSFPLASA-N 0.000 description 3
PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 2
BCMCBBGGLRIHSE-UHFFFAOYSA-N 1,3-benzoxazole Chemical compound C1=CC=C2OC=NC2=C1 BCMCBBGGLRIHSE-UHFFFAOYSA-N 0.000 description 2
FLBAYUMRQUHISI-UHFFFAOYSA-N 1,8-naphthyridine Chemical compound N1=CC=CC2=CC=CN=C21 FLBAYUMRQUHISI-UHFFFAOYSA-N 0.000 description 2
MRBFGEHILMYPTF-UHFFFAOYSA-N 1-(2-Pyrimidyl)piperazine Chemical compound C1CNCCN1C1=NC=CC=N1 MRBFGEHILMYPTF-UHFFFAOYSA-N 0.000 description 2
ZACLFWISXHXZSS-UHFFFAOYSA-N 1-(6-bromo-2-chloroquinolin-4-yl)-3-[2-(diethylamino)ethyl]urea Chemical compound C1=C(Br)C=C2C(NC(=O)NCCN(CC)CC)=CC(Cl)=NC2=C1 ZACLFWISXHXZSS-UHFFFAOYSA-N 0.000 description 2
WSXOKTKQMKXUKK-UHFFFAOYSA-N 1-azabicyclo[2.2.2]octan-3-yl n-[2-[(2-methylnaphthalen-1-yl)methylsulfanyl]phenyl]carbamate Chemical compound C1N(CC2)CCC2C1OC(=O)NC1=CC=CC=C1SCC1=C2C=CC=CC2=CC=C1C WSXOKTKQMKXUKK-UHFFFAOYSA-N 0.000 description 2
VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
LVGIUOZGDVZIMK-UHFFFAOYSA-N 1-sulfanylpyrrolidine Chemical compound SN1CCCC1 LVGIUOZGDVZIMK-UHFFFAOYSA-N 0.000 description 2
YQQSRZSUGBETRS-UHFFFAOYSA-N 1h-pyridazine-6-thione Chemical compound SC1=CC=CN=N1 YQQSRZSUGBETRS-UHFFFAOYSA-N 0.000 description 2
QGXNHCXKWFNKCG-UHFFFAOYSA-N 2-(bromomethyl)benzonitrile Chemical compound BrCC1=CC=CC=C1C#N QGXNHCXKWFNKCG-UHFFFAOYSA-N 0.000 description 2
KKWGREIGMAWSGA-UHFFFAOYSA-N 2-[2-[(2-methoxy-5-methylphenyl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(C)C=C1CSC1=CC=CC=C1C1=NCCCN1 KKWGREIGMAWSGA-UHFFFAOYSA-N 0.000 description 2
HJWLUEOYGAIIGV-UHFFFAOYSA-N 2-[2-[(5-iodo-2-methoxyphenyl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(I)C=C1CSC1=CC=CC=C1C1=NCCCN1 HJWLUEOYGAIIGV-UHFFFAOYSA-N 0.000 description 2
NAPYCAWRLDPGFK-UHFFFAOYSA-N 2-[2-[[2-methoxy-5-(2-phenylethynyl)phenyl]methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(C#CC=2C=CC=CC=2)C=C1CSC1=CC=CC=C1C1=NCCCN1 NAPYCAWRLDPGFK-UHFFFAOYSA-N 0.000 description 2
OXYGFGRBQBBYLQ-UHFFFAOYSA-N 2-[2-[[2-methoxy-5-(trifluoromethyl)phenyl]methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(C(F)(F)F)C=C1CSC1=CC=CC=C1C1=NCCCN1 OXYGFGRBQBBYLQ-UHFFFAOYSA-N 0.000 description 2
OQQKRORCCALBOF-UHFFFAOYSA-N 3-(2-methylpiperidin-1-yl)-n-[[2-(2-naphthalen-1-ylethyl)phenyl]methyl]propan-1-amine Chemical compound CC1CCCCN1CCCNCC1=CC=CC=C1CCC1=CC=CC2=CC=CC=C12 OQQKRORCCALBOF-UHFFFAOYSA-N 0.000 description 2
KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
108091003079 Bovine Serum Albumin Proteins 0.000 description 2
239000004322 Butylated hydroxytoluene Substances 0.000 description 2
NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 2
VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
GJSURZIOUXUGAL-UHFFFAOYSA-N Clonidine Chemical compound ClC1=CC=CC(Cl)=C1NC1=NCCN1 GJSURZIOUXUGAL-UHFFFAOYSA-N 0.000 description 2
108091026890 Coding region Proteins 0.000 description 2
229940126062 Compound A Drugs 0.000 description 2
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 2
IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 2
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
239000004278 EU approved seasoning Substances 0.000 description 2
QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 2
102000003688 G-Protein-Coupled Receptors Human genes 0.000 description 2
108090000045 G-Protein-Coupled Receptors Proteins 0.000 description 2
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 2
235000010643 Leucaena leucocephala Nutrition 0.000 description 2
240000007472 Leucaena leucocephala Species 0.000 description 2
102000017351 Melanocortin 3 receptors Human genes 0.000 description 2
102400000740 Melanocyte-stimulating hormone alpha Human genes 0.000 description 2
101710200814 Melanotropin alpha Proteins 0.000 description 2
101100129532 Mus musculus Mc4r gene Proteins 0.000 description 2
MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 2
206010028980 Neoplasm Diseases 0.000 description 2
ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 2
235000019483 Peanut oil Nutrition 0.000 description 2
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
ATTZFSUZZUNHBP-UHFFFAOYSA-N Piperonyl sulfoxide Chemical compound CCCCCCCCS(=O)C(C)CC1=CC=C2OCOC2=C1 ATTZFSUZZUNHBP-UHFFFAOYSA-N 0.000 description 2
108010069820 Pro-Opiomelanocortin Proteins 0.000 description 2
239000000683 Pro-Opiomelanocortin Substances 0.000 description 2
ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 2
108700008625 Reporter Genes Proteins 0.000 description 2
CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 2
239000007983 Tris buffer Substances 0.000 description 2
108010021430 Type 2 Melanocortin Receptor Proteins 0.000 description 2
108010021433 Type 3 Melanocortin Receptor Proteins 0.000 description 2
XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
RWRGOKPWZKWGMF-UHFFFAOYSA-N [2-(naphthalen-1-ylmethylsulfanyl)phenyl]carbamic acid Chemical compound OC(=O)NC1=CC=CC=C1SCC1=CC=CC2=CC=CC=C12 RWRGOKPWZKWGMF-UHFFFAOYSA-N 0.000 description 2
230000009471 action Effects 0.000 description 2
230000002411 adverse Effects 0.000 description 2
150000001298 alcohols Chemical class 0.000 description 2
239000000783 alginic acid Substances 0.000 description 2
229960001126 alginic acid Drugs 0.000 description 2
150000004781 alginic acids Chemical class 0.000 description 2
125000004183 alkoxy alkyl group Chemical group 0.000 description 2
229910052782 aluminium Inorganic materials 0.000 description 2
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 2
229910000147 aluminium phosphate Inorganic materials 0.000 description 2
229940024606 amino acid Drugs 0.000 description 2
235000001014 amino acid Nutrition 0.000 description 2
238000010171 animal model Methods 0.000 description 2
125000002178 anthracenyl group Chemical group C1(=CC=CC2=CC3=CC=CC=C3C=C12)* 0.000 description 2
125000003435 aroyl group Chemical group 0.000 description 2
125000005018 aryl alkenyl group Chemical group 0.000 description 2
IVRMZWNICZWHMI-UHFFFAOYSA-N azide group Chemical group [N-]=[N+]=[N-] IVRMZWNICZWHMI-UHFFFAOYSA-N 0.000 description 2
230000008901 benefit Effects 0.000 description 2
239000000440 bentonite Substances 0.000 description 2
229910000278 bentonite Inorganic materials 0.000 description 2
235000012216 bentonite Nutrition 0.000 description 2
SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
239000011230 binding agent Substances 0.000 description 2
229920002988 biodegradable polymer Polymers 0.000 description 2
239000004621 biodegradable polymer Substances 0.000 description 2
239000008280 blood Substances 0.000 description 2
210000004369 blood Anatomy 0.000 description 2
230000036760 body temperature Effects 0.000 description 2
230000037396 body weight Effects 0.000 description 2
235000010354 butylated hydroxytoluene Nutrition 0.000 description 2
229940095259 butylated hydroxytoluene Drugs 0.000 description 2
201000011510 cancer Diseases 0.000 description 2
239000004202 carbamide Substances 0.000 description 2
125000005708 carbonyloxy group Chemical group [*:2]OC([*:1])=O 0.000 description 2
239000001768 carboxy methyl cellulose Substances 0.000 description 2
150000001735 carboxylic acids Chemical class 0.000 description 2
238000000423 cell based assay Methods 0.000 description 2
238000005119 centrifugation Methods 0.000 description 2
239000003610 charcoal Substances 0.000 description 2
OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 2
229960002896 clonidine Drugs 0.000 description 2
238000010367 cloning Methods 0.000 description 2
235000019868 cocoa butter Nutrition 0.000 description 2
229940110456 cocoa butter Drugs 0.000 description 2
239000003086 colorant Substances 0.000 description 2
238000007796 conventional method Methods 0.000 description 2
235000012343 cottonseed oil Nutrition 0.000 description 2
239000002385 cottonseed oil Substances 0.000 description 2
239000013078 crystal Substances 0.000 description 2
125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 2
125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 2
125000003493 decenyl group Chemical group [H]C([*])=C([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
150000004985 diamines Chemical class 0.000 description 2
239000003085 diluting agent Substances 0.000 description 2
239000007884 disintegrant Substances 0.000 description 2
239000008298 dragée Substances 0.000 description 2
239000000839 emulsion Substances 0.000 description 2
239000003623 enhancer Substances 0.000 description 2
MMXKVMNBHPAILY-UHFFFAOYSA-N ethyl laurate Chemical compound CCCCCCCCCCCC(=O)OCC MMXKVMNBHPAILY-UHFFFAOYSA-N 0.000 description 2
239000012091 fetal bovine serum Substances 0.000 description 2
239000000945 filler Substances 0.000 description 2
125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 description 2
235000011194 food seasoning agent Nutrition 0.000 description 2
239000012458 free base Substances 0.000 description 2
125000000524 functional group Chemical group 0.000 description 2
239000008103 glucose Substances 0.000 description 2
125000004404 heteroalkyl group Chemical group 0.000 description 2
150000002391 heterocyclic compounds Chemical class 0.000 description 2
125000006038 hexenyl group Chemical group 0.000 description 2
125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
230000013632 homeostatic process Effects 0.000 description 2
229930195733 hydrocarbon Natural products 0.000 description 2
229910000037 hydrogen sulfide Inorganic materials 0.000 description 2
MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 2
238000000338 in vitro Methods 0.000 description 2
238000005462 in vivo assay Methods 0.000 description 2
PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 2
RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 2
238000007918 intramuscular administration Methods 0.000 description 2
ZLTPDFXIESTBQG-UHFFFAOYSA-N isothiazole Chemical compound C=1C=NSC=1 ZLTPDFXIESTBQG-UHFFFAOYSA-N 0.000 description 2
CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 description 2
239000000787 lecithin Substances 0.000 description 2
235000010445 lecithin Nutrition 0.000 description 2
229940067606 lecithin Drugs 0.000 description 2
239000002502 liposome Substances 0.000 description 2
239000008297 liquid dosage form Substances 0.000 description 2
239000006210 lotion Substances 0.000 description 2
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
235000010355 mannitol Nutrition 0.000 description 2
239000011159 matrix material Substances 0.000 description 2
230000001404 mediated effect Effects 0.000 description 2
230000004060 metabolic process Effects 0.000 description 2
229910052751 metal Inorganic materials 0.000 description 2
239000002184 metal Substances 0.000 description 2
BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
150000007522 mineralic acids Chemical class 0.000 description 2
229960005016 naphazoline Drugs 0.000 description 2
125000005187 nonenyl group Chemical group C(=CCCCCCCC)* 0.000 description 2
125000004365 octenyl group Chemical group C(=CCCCCCC)* 0.000 description 2
229940049964 oleate Drugs 0.000 description 2
ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
210000000056 organ Anatomy 0.000 description 2
239000000312 peanut oil Substances 0.000 description 2
125000002255 pentenyl group Chemical group C(=CCCC)* 0.000 description 2
239000000137 peptide hydrolase inhibitor Substances 0.000 description 2
229910000073 phosphorus hydride Inorganic materials 0.000 description 2
229920005862 polyol Polymers 0.000 description 2
150000003077 polyols Chemical class 0.000 description 2
230000003389 potentiating effect Effects 0.000 description 2
230000002265 prevention Effects 0.000 description 2
102000004196 processed proteins & peptides Human genes 0.000 description 2
108090000765 processed proteins & peptides Proteins 0.000 description 2
229960004063 propylene glycol Drugs 0.000 description 2
GZRKXKUVVPSREJ-UHFFFAOYSA-N pyridinylpiperazine Chemical compound C1CNCCN1C1=CC=CC=N1 GZRKXKUVVPSREJ-UHFFFAOYSA-N 0.000 description 2
WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 description 2
125000005493 quinolyl group Chemical group 0.000 description 2
230000001105 regulatory effect Effects 0.000 description 2
238000012216 screening Methods 0.000 description 2
238000007423 screening assay Methods 0.000 description 2
239000008159 sesame oil Substances 0.000 description 2
235000011803 sesame oil Nutrition 0.000 description 2
230000019491 signal transduction Effects 0.000 description 2
239000000741 silica gel Substances 0.000 description 2
229910002027 silica gel Inorganic materials 0.000 description 2
RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 2
235000012239 silicon dioxide Nutrition 0.000 description 2
235000019333 sodium laurylsulphate Nutrition 0.000 description 2
239000008279 sol Substances 0.000 description 2
239000007909 solid dosage form Substances 0.000 description 2
239000008247 solid mixture Substances 0.000 description 2
239000000600 sorbitol Substances 0.000 description 2
239000003549 soybean oil Substances 0.000 description 2
235000012424 soybean oil Nutrition 0.000 description 2
238000010561 standard procedure Methods 0.000 description 2
125000000547 substituted alkyl group Chemical group 0.000 description 2
125000004426 substituted alkynyl group Chemical group 0.000 description 2
235000000346 sugar Nutrition 0.000 description 2
230000002194 synthesizing effect Effects 0.000 description 2
239000006188 syrup Substances 0.000 description 2
235000020357 syrup Nutrition 0.000 description 2
150000003536 tetrazoles Chemical class 0.000 description 2
BRNULMACUQOKMR-UHFFFAOYSA-N thiomorpholine Chemical compound C1CSCCN1 BRNULMACUQOKMR-UHFFFAOYSA-N 0.000 description 2
229960002312 tolazoline Drugs 0.000 description 2
VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
125000004784 trichloromethoxy group Chemical group ClC(O*)(Cl)Cl 0.000 description 2
125000003866 trichloromethyl group Chemical group ClC(Cl)(Cl)* 0.000 description 2
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
150000004670 unsaturated fatty acids Chemical class 0.000 description 2
235000021122 unsaturated fatty acids Nutrition 0.000 description 2
235000015112 vegetable and seed oil Nutrition 0.000 description 2
QIJRTFXNRTXDIP-UHFFFAOYSA-N (1-carboxy-2-sulfanylethyl)azanium;chloride;hydrate Chemical compound O.Cl.SCC(N)C(O)=O QIJRTFXNRTXDIP-UHFFFAOYSA-N 0.000 description 1
GVJHHUAWPYXKBD-IEOSBIPESA-N (R)-alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
229940058015 1,3-butylene glycol Drugs 0.000 description 1
XMWGTKZEDLCVIG-UHFFFAOYSA-N 1-(chloromethyl)naphthalene Chemical compound C1=CC=C2C(CCl)=CC=CC2=C1 XMWGTKZEDLCVIG-UHFFFAOYSA-N 0.000 description 1
WSEQXVZVJXJVFP-UHFFFAOYSA-N 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile Chemical compound O1CC2=CC(C#N)=CC=C2C1(CCCN(C)C)C1=CC=C(F)C=C1 WSEQXVZVJXJVFP-UHFFFAOYSA-N 0.000 description 1
FRFKCMNQNNNZNO-UHFFFAOYSA-N 1-[3-(trifluoromethyl)pyridin-2-yl]piperazine Chemical compound FC(F)(F)C1=CC=CN=C1N1CCNCC1 FRFKCMNQNNNZNO-UHFFFAOYSA-N 0.000 description 1
BNMSJUIMZULLAS-UHFFFAOYSA-N 1-[5-(trifluoromethyl)pyridin-2-yl]piperazine Chemical compound N1=CC(C(F)(F)F)=CC=C1N1CCNCC1 BNMSJUIMZULLAS-UHFFFAOYSA-N 0.000 description 1
BCQNKADIWADQCL-UHFFFAOYSA-N 1-[[2-(naphthalen-1-ylsulfanylmethyl)phenyl]methyl]piperazine Chemical compound C=1C=CC2=CC=CC=C2C=1SCC1=CC=CC=C1CN1CCNCC1 BCQNKADIWADQCL-UHFFFAOYSA-N 0.000 description 1
JLYBRUBFGATRBM-UHFFFAOYSA-N 1-[[3-chloro-2-(naphthalen-1-ylsulfanylmethyl)phenyl]methyl]piperazine Chemical compound C=1C=CC2=CC=CC=C2C=1SCC=1C(Cl)=CC=CC=1CN1CCNCC1 JLYBRUBFGATRBM-UHFFFAOYSA-N 0.000 description 1
HVDWCFNXMDSFSR-UHFFFAOYSA-N 1-azabicyclo[2.2.2]octan-3-yl n-[2-(naphthalen-1-ylmethylsulfanyl)phenyl]carbamate Chemical compound C1N(CC2)CCC2C1OC(=O)NC1=CC=CC=C1SCC1=CC=CC2=CC=CC=C12 HVDWCFNXMDSFSR-UHFFFAOYSA-N 0.000 description 1
LDMOEFOXLIZJOW-UHFFFAOYSA-N 1-dodecanesulfonic acid Chemical compound CCCCCCCCCCCCS(O)(=O)=O LDMOEFOXLIZJOW-UHFFFAOYSA-N 0.000 description 1
DFGJILDDYSPIIG-UHFFFAOYSA-N 2-(2,6-dichlorophenyl)-1h-imidazole Chemical compound ClC1=CC=CC(Cl)=C1C1=NC=CN1 DFGJILDDYSPIIG-UHFFFAOYSA-N 0.000 description 1
VBGDTCBHSKWUHT-UHFFFAOYSA-N 2-(2-benzylsulfanylphenyl)-4,5-dihydro-1h-imidazole Chemical compound C=1C=CC=CC=1CSC1=CC=CC=C1C1=NCCN1 VBGDTCBHSKWUHT-UHFFFAOYSA-N 0.000 description 1
UFGOFMCEZLRIJD-UHFFFAOYSA-N 2-(2-naphthalen-1-ylethyl)benzonitrile Chemical compound N#CC1=CC=CC=C1CCC1=CC=CC2=CC=CC=C12 UFGOFMCEZLRIJD-UHFFFAOYSA-N 0.000 description 1
ORVKGXPJZJAEEK-UHFFFAOYSA-N 2-(3-aminopropylamino)-6-[(5-bromo-2-methoxyphenyl)methylsulfanyl]benzonitrile Chemical compound COC1=CC=C(Br)C=C1CSC1=CC=CC(NCCCN)=C1C#N ORVKGXPJZJAEEK-UHFFFAOYSA-N 0.000 description 1
DRZIZNYOPFSEDH-UHFFFAOYSA-N 2-(fluoromethyl)pyrimidine Chemical compound FCC1=NC=CC=N1 DRZIZNYOPFSEDH-UHFFFAOYSA-N 0.000 description 1
BPGGBTUYXDFQIR-UHFFFAOYSA-N 2-(naphthalen-1-ylmethylsulfanyl)-3-(1,4,5,6-tetrahydropyrimidin-2-yl)aniline Chemical compound C=1C=CC2=CC=CC=C2C=1CSC=1C(N)=CC=CC=1C1=NCCCN1 BPGGBTUYXDFQIR-UHFFFAOYSA-N 0.000 description 1
VXYAUHIPEGXCOZ-UHFFFAOYSA-N 2-[(5-bromo-2-methoxyphenyl)sulfanylmethyl]benzonitrile Chemical compound COC1=CC=C(Br)C=C1SCC1=CC=CC=C1C#N VXYAUHIPEGXCOZ-UHFFFAOYSA-N 0.000 description 1
VJKACOCRHHQFEQ-UHFFFAOYSA-N 2-[2-(naphthalen-1-ylsulfanylmethyl)phenyl]piperidine Chemical compound C=1C=CC2=CC=CC=C2C=1SCC1=CC=CC=C1C1CCCCN1 VJKACOCRHHQFEQ-UHFFFAOYSA-N 0.000 description 1
LTWCBBRXEBVHTH-UHFFFAOYSA-N 2-[2-[(2,5-dichlorothiophen-3-yl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound S1C(Cl)=CC(CSC=2C(=CC=CC=2)C=2NCCCN=2)=C1Cl LTWCBBRXEBVHTH-UHFFFAOYSA-N 0.000 description 1
FGRRSCLWFFIDDZ-UHFFFAOYSA-N 2-[2-[(2-bromo-5-methoxyphenyl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(Br)C(CSC=2C(=CC=CC=2)C=2NCCCN=2)=C1 FGRRSCLWFFIDDZ-UHFFFAOYSA-N 0.000 description 1
PRRRRTXDJJLOLL-UHFFFAOYSA-N 2-[2-[(2-bromo-6-methoxyphenyl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=CC(Br)=C1CSC1=CC=CC=C1C1=NCCCN1 PRRRRTXDJJLOLL-UHFFFAOYSA-N 0.000 description 1
KEDBEJDOVCGYMS-UHFFFAOYSA-N 2-[2-[(2-bromophenyl)sulfanylmethyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound BrC1=CC=CC=C1SCC1=CC=CC=C1C1=NCCCN1 KEDBEJDOVCGYMS-UHFFFAOYSA-N 0.000 description 1
LTKNAMJHFJKCLP-UHFFFAOYSA-N 2-[2-[(2-chloro-6-fluorophenyl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound FC1=CC=CC(Cl)=C1CSC1=CC=CC=C1C1=NCCCN1 LTKNAMJHFJKCLP-UHFFFAOYSA-N 0.000 description 1
VKOWVQSIVDKTFD-UHFFFAOYSA-N 2-[2-[(2-cyclopentyloxyphenyl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound C=1C=CC=C(OC2CCCC2)C=1CSC1=CC=CC=C1C1=NCCCN1 VKOWVQSIVDKTFD-UHFFFAOYSA-N 0.000 description 1
RLQOQTQCFAZGSR-UHFFFAOYSA-N 2-[2-[(2-ethoxynaphthalen-1-yl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound CCOC1=CC=C2C=CC=CC2=C1CSC1=CC=CC=C1C1=NCCCN1 RLQOQTQCFAZGSR-UHFFFAOYSA-N 0.000 description 1
CGDASKIJYYWJSM-UHFFFAOYSA-N 2-[2-[(2-methoxy-5-phenylphenyl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(C=2C=CC=CC=2)C=C1CSC1=CC=CC=C1C1=NCCCN1 CGDASKIJYYWJSM-UHFFFAOYSA-N 0.000 description 1
GMKOONYUECAQPJ-UHFFFAOYSA-N 2-[2-[(2-methoxy-5-thiophen-3-ylphenyl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(C2=CSC=C2)C=C1CSC1=CC=CC=C1C1=NCCCN1 GMKOONYUECAQPJ-UHFFFAOYSA-N 0.000 description 1
JDLIHUYYNCQAES-UHFFFAOYSA-N 2-[2-[(2-methoxynaphthalen-1-yl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C2C=CC=CC2=C1CSC1=CC=CC=C1C1=NCCCN1 JDLIHUYYNCQAES-UHFFFAOYSA-N 0.000 description 1
NUTDJMUUFLZXSZ-UHFFFAOYSA-N 2-[2-[(2-methoxynaphthalen-1-yl)sulfanylmethyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C2C=CC=CC2=C1SCC1=CC=CC=C1C1=NCCCN1 NUTDJMUUFLZXSZ-UHFFFAOYSA-N 0.000 description 1
LOPZEVFRRBDVPB-UHFFFAOYSA-N 2-[2-[(2-methylphenyl)sulfanylmethyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound CC1=CC=CC=C1SCC1=CC=CC=C1C1=NCCCN1 LOPZEVFRRBDVPB-UHFFFAOYSA-N 0.000 description 1
PHPOZVKYMNDMHX-UHFFFAOYSA-N 2-[2-[(2-phenylphenyl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound C=1C=CC=C(C=2C=CC=CC=2)C=1CSC1=CC=CC=C1C1=NCCCN1 PHPOZVKYMNDMHX-UHFFFAOYSA-N 0.000 description 1
MVFGKBOVQQMARR-UHFFFAOYSA-N 2-[2-[(2-propoxynaphthalen-1-yl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound CCCOC1=CC=C2C=CC=CC2=C1CSC1=CC=CC=C1C1=NCCCN1 MVFGKBOVQQMARR-UHFFFAOYSA-N 0.000 description 1
PXBUAHNXIUFNNY-UHFFFAOYSA-N 2-[2-[(5-bromo-2-methoxyphenyl)methoxy]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(Br)C=C1COC1=CC=CC=C1C1=NCCCN1 PXBUAHNXIUFNNY-UHFFFAOYSA-N 0.000 description 1
FOVOETZPEDCAOZ-UHFFFAOYSA-N 2-[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]-3,5-difluorophenyl]-5,5-dimethyl-1,4-dihydroimidazole Chemical compound COC1=CC=C(Br)C=C1CSC1=C(F)C=C(F)C=C1C1=NCC(C)(C)N1 FOVOETZPEDCAOZ-UHFFFAOYSA-N 0.000 description 1
XDPJOQZPTYODRK-UHFFFAOYSA-N 2-[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]-3-fluorophenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(Br)C=C1CSC1=C(F)C=CC=C1C1=NCCCN1 XDPJOQZPTYODRK-UHFFFAOYSA-N 0.000 description 1
RHYDIGSQSONJBK-UHFFFAOYSA-N 2-[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]-3-fluorophenyl]-5,5-dimethyl-1,4-dihydroimidazole Chemical compound COC1=CC=C(Br)C=C1CSC1=C(F)C=CC=C1C1=NC(C)(C)CN1 RHYDIGSQSONJBK-UHFFFAOYSA-N 0.000 description 1
RTXJBQSGOVXPQR-UHFFFAOYSA-N 2-[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]-3-fluorophenyl]-5,5-dimethyl-4,6-dihydro-1h-pyrimidine Chemical compound COC1=CC=C(Br)C=C1CSC1=C(F)C=CC=C1C1=NCC(C)(C)CN1 RTXJBQSGOVXPQR-UHFFFAOYSA-N 0.000 description 1
OOYYKTSPPNPIOS-UHFFFAOYSA-N 2-[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]-3-fluorophenyl]-5-methyl-4,5-dihydro-1h-imidazole Chemical compound COC1=CC=C(Br)C=C1CSC1=C(F)C=CC=C1C1=NC(C)CN1 OOYYKTSPPNPIOS-UHFFFAOYSA-N 0.000 description 1
AKAKMYRPGCQWGD-UHFFFAOYSA-N 2-[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]-5-fluorophenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(Br)C=C1CSC1=CC=C(F)C=C1C1=NCCCN1 AKAKMYRPGCQWGD-UHFFFAOYSA-N 0.000 description 1
ZECWULPQHNOWRR-UHFFFAOYSA-N 2-[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]-5-fluorophenyl]-4,5-dihydro-1h-imidazole Chemical compound COC1=CC=C(Br)C=C1CSC1=CC=C(F)C=C1C1=NCCN1 ZECWULPQHNOWRR-UHFFFAOYSA-N 0.000 description 1
LRARSJZZXIOEEO-UHFFFAOYSA-N 2-[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]-5-methylphenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(Br)C=C1CSC1=CC=C(C)C=C1C1=NCCCN1 LRARSJZZXIOEEO-UHFFFAOYSA-N 0.000 description 1
JYSMBTPEJSZMPQ-UHFFFAOYSA-N 2-[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]phenyl]-4,5-dihydro-1h-imidazole Chemical compound COC1=CC=C(Br)C=C1CSC1=CC=CC=C1C1=NCCN1 JYSMBTPEJSZMPQ-UHFFFAOYSA-N 0.000 description 1
NYPTVDKJISWLDP-UHFFFAOYSA-N 2-[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]phenyl]-5,5-dimethyl-1,4-dihydroimidazole Chemical compound COC1=CC=C(Br)C=C1CSC1=CC=CC=C1C1=NCC(C)(C)N1 NYPTVDKJISWLDP-UHFFFAOYSA-N 0.000 description 1
WFGIAUVZRWXFIJ-UHFFFAOYSA-N 2-[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]phenyl]-5,5-dimethyl-4,6-dihydro-1h-pyrimidine Chemical compound COC1=CC=C(Br)C=C1CSC1=CC=CC=C1C1=NCC(C)(C)CN1 WFGIAUVZRWXFIJ-UHFFFAOYSA-N 0.000 description 1
SMZVQYVSTZGACP-UHFFFAOYSA-N 2-[2-[(5-bromo-2-methoxyphenyl)methylsulfanylmethyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(Br)C=C1CSCC1=CC=CC=C1C1=NCCCN1 SMZVQYVSTZGACP-UHFFFAOYSA-N 0.000 description 1
VJCWFTJNIJPWCW-UHFFFAOYSA-N 2-[2-[(5-bromo-2-propan-2-yloxyphenyl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound CC(C)OC1=CC=C(Br)C=C1CSC1=CC=CC=C1C1=NCCCN1 VJCWFTJNIJPWCW-UHFFFAOYSA-N 0.000 description 1
YOHMIPZLDKWENG-UHFFFAOYSA-N 2-[2-[(5-chloro-2-methoxyphenyl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(Cl)C=C1CSC1=CC=CC=C1C1=NCCCN1 YOHMIPZLDKWENG-UHFFFAOYSA-N 0.000 description 1
XAJUEBVKLILWRA-UHFFFAOYSA-N 2-[2-[(5-fluoro-2-methoxyphenyl)methylsulfanyl]phenyl]-4,5-dihydro-1h-imidazole Chemical compound COC1=CC=C(F)C=C1CSC1=CC=CC=C1C1=NCCN1 XAJUEBVKLILWRA-UHFFFAOYSA-N 0.000 description 1
TYHWUSYRUAHMBB-UHFFFAOYSA-N 2-[2-[(6-fluoronaphthalen-1-yl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound C=1C=CC2=CC(F)=CC=C2C=1CSC1=CC=CC=C1C1=NCCCN1 TYHWUSYRUAHMBB-UHFFFAOYSA-N 0.000 description 1
FFFXXFREPCGSFR-UHFFFAOYSA-N 2-[2-[1-(5-bromo-2-methoxyphenyl)propan-2-yl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(Br)C=C1CC(C)C1=CC=CC=C1C1=NCCCN1 FFFXXFREPCGSFR-UHFFFAOYSA-N 0.000 description 1
GYJLBLSVLQVQOR-UHFFFAOYSA-N 2-[2-[2-(2-methoxynaphthalen-1-yl)ethyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C2C=CC=CC2=C1CCC1=CC=CC=C1C1=NCCCN1 GYJLBLSVLQVQOR-UHFFFAOYSA-N 0.000 description 1
XDMDMDPCJLVGGW-UHFFFAOYSA-N 2-[2-[2-(5-bromo-2-methoxyphenyl)ethyl]-3-chlorophenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(Br)C=C1CCC1=C(Cl)C=CC=C1C1=NCCCN1 XDMDMDPCJLVGGW-UHFFFAOYSA-N 0.000 description 1
GPVZZAYIPVQEAG-UHFFFAOYSA-N 2-[2-[2-(5-bromo-2-methoxyphenyl)ethyl]-3-fluorophenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(Br)C=C1CCC1=C(F)C=CC=C1C1=NCCCN1 GPVZZAYIPVQEAG-UHFFFAOYSA-N 0.000 description 1
QMKKPQXQBBNKQM-UHFFFAOYSA-N 2-[2-[2-(5-bromo-2-methoxyphenyl)ethyl]-3-methoxyphenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(Br)C=C1CCC1=C(OC)C=CC=C1C1=NCCCN1 QMKKPQXQBBNKQM-UHFFFAOYSA-N 0.000 description 1
CCISHMCRIWHRTE-UHFFFAOYSA-N 2-[2-[[2,4-bis(trifluoromethyl)phenyl]methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound FC(F)(F)C1=CC(C(F)(F)F)=CC=C1CSC1=CC=CC=C1C1=NCCCN1 CCISHMCRIWHRTE-UHFFFAOYSA-N 0.000 description 1
BQGMRZMJHCNXDE-UHFFFAOYSA-N 2-[2-[[2-methoxy-5-(4-methoxyphenyl)phenyl]methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound C1=CC(OC)=CC=C1C1=CC=C(OC)C(CSC=2C(=CC=CC=2)C=2NCCCN=2)=C1 BQGMRZMJHCNXDE-UHFFFAOYSA-N 0.000 description 1
RBUZILJRVMVRED-UHFFFAOYSA-N 2-[2-[[3,5-bis(trifluoromethyl)phenyl]methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound FC(F)(F)C1=CC(C(F)(F)F)=CC(CSC=2C(=CC=CC=2)C=2NCCCN=2)=C1 RBUZILJRVMVRED-UHFFFAOYSA-N 0.000 description 1
WUPHVXHCTSWGPA-UHFFFAOYSA-N 2-[3-chloro-2-[(2-methoxynaphthalen-1-yl)sulfanylmethyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C2C=CC=CC2=C1SCC1=C(Cl)C=CC=C1C1=NCCCN1 WUPHVXHCTSWGPA-UHFFFAOYSA-N 0.000 description 1
VSLAWUJINZENSD-UHFFFAOYSA-N 2-[3-fluoro-2-(naphthalen-1-ylmethylsulfanyl)phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound C=1C=CC2=CC=CC=C2C=1CSC=1C(F)=CC=CC=1C1=NCCCN1 VSLAWUJINZENSD-UHFFFAOYSA-N 0.000 description 1
XROBCDNMROGODT-UHFFFAOYSA-N 2-[3-fluoro-2-(naphthalen-1-ylsulfanylmethyl)phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound C=1C=CC2=CC=CC=C2C=1SCC=1C(F)=CC=CC=1C1=NCCCN1 XROBCDNMROGODT-UHFFFAOYSA-N 0.000 description 1
IAHONBQOZYLKBE-UHFFFAOYSA-N 2-[4-bromo-2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(Br)C=C1CSC1=CC(Br)=CC=C1C1=NCCCN1 IAHONBQOZYLKBE-UHFFFAOYSA-N 0.000 description 1
QQZLNBLGDXQLHB-UHFFFAOYSA-N 2-[5-bromo-2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(Br)C=C1CSC1=CC=C(Br)C=C1C1=NCCCN1 QQZLNBLGDXQLHB-UHFFFAOYSA-N 0.000 description 1
QZTCPOQRAKEEBS-UHFFFAOYSA-N 2-[5-bromo-2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]phenyl]-4,5-dihydro-1h-imidazole Chemical compound COC1=CC=C(Br)C=C1CSC1=CC=C(Br)C=C1C1=NCCN1 QZTCPOQRAKEEBS-UHFFFAOYSA-N 0.000 description 1
ZDCKTYHRUDDTRR-UHFFFAOYSA-N 2-amino-2-[2-(2-naphthalen-1-ylethyl)phenyl]acetonitrile Chemical compound N#CC(N)C1=CC=CC=C1CCC1=CC=CC2=CC=CC=C12 ZDCKTYHRUDDTRR-UHFFFAOYSA-N 0.000 description 1
SCVJRXQHFJXZFZ-KVQBGUIXSA-N 2-amino-9-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3h-purine-6-thione Chemical compound C1=2NC(N)=NC(=S)C=2N=CN1[C@H]1C[C@H](O)[C@@H](CO)O1 SCVJRXQHFJXZFZ-KVQBGUIXSA-N 0.000 description 1
YUQUNWNSQDULTI-UHFFFAOYSA-N 2-bromobenzenethiol Chemical compound SC1=CC=CC=C1Br YUQUNWNSQDULTI-UHFFFAOYSA-N 0.000 description 1
125000006276 2-bromophenyl group Chemical group [H]C1=C([H])C(Br)=C(*)C([H])=C1[H] 0.000 description 1
125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 description 1
XIMFTYYMYOBGOG-UHFFFAOYSA-N 2-hydroxy-2-(2-oxo-2-propoxyethyl)butanedioic acid Chemical compound CCCOC(=O)CC(O)(C(O)=O)CC(O)=O XIMFTYYMYOBGOG-UHFFFAOYSA-N 0.000 description 1
LODHFNUFVRVKTH-ZHACJKMWSA-N 2-hydroxy-n'-[(e)-3-phenylprop-2-enoyl]benzohydrazide Chemical group OC1=CC=CC=C1C(=O)NNC(=O)\C=C\C1=CC=CC=C1 LODHFNUFVRVKTH-ZHACJKMWSA-N 0.000 description 1
125000006304 2-iodophenyl group Chemical group [H]C1=C([H])C(I)=C(*)C([H])=C1[H] 0.000 description 1
125000004204 2-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C(OC([H])([H])[H])C([H])=C1[H] 0.000 description 1
WBJVPAABGFBMJQ-UHFFFAOYSA-N 2-piperazin-1-yl-4-(trifluoromethyl)pyrimidine Chemical compound FC(F)(F)C1=CC=NC(N2CCNCC2)=N1 WBJVPAABGFBMJQ-UHFFFAOYSA-N 0.000 description 1
SNXAPSQAOUWUBO-UHFFFAOYSA-N 3-(2-naphthalen-1-ylethyl)-2-(1,4,5,6-tetrahydropyrimidin-2-yl)aniline Chemical compound NC1=CC=CC(CCC=2C3=CC=CC=C3C=CC=2)=C1C1=NCCCN1 SNXAPSQAOUWUBO-UHFFFAOYSA-N 0.000 description 1
QVEWNZMMZGKMOK-UHFFFAOYSA-N 3-[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]-3-fluorophenyl]-1,5,6,7,8,8a-hexahydroimidazo[1,5-a]pyridine Chemical compound COC1=CC=C(Br)C=C1CSC1=C(F)C=CC=C1C1=NCC2N1CCCC2 QVEWNZMMZGKMOK-UHFFFAOYSA-N 0.000 description 1
NPCMACUQHBFXEO-UHFFFAOYSA-N 3-[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]-3-fluorophenyl]-5,6,7,7a-tetrahydro-1h-pyrrolo[1,2-c]imidazole Chemical compound COC1=CC=C(Br)C=C1CSC1=C(F)C=CC=C1C1=NCC2N1CCC2 NPCMACUQHBFXEO-UHFFFAOYSA-N 0.000 description 1
KGMGBTYHOQWYMB-UHFFFAOYSA-N 3-[[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]phenyl]methoxy]pyrrolidine Chemical compound COC1=CC=C(Br)C=C1CSC1=CC=CC=C1COC1CNCC1 KGMGBTYHOQWYMB-UHFFFAOYSA-N 0.000 description 1
VRMGVFAVTFUVOZ-UHFFFAOYSA-N 3-[[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]phenyl]methylamino]-3-methylbutan-1-ol Chemical compound COC1=CC=C(Br)C=C1CSC1=CC=CC=C1CNC(C)(C)CCO VRMGVFAVTFUVOZ-UHFFFAOYSA-N 0.000 description 1
YHFJHNVCVXVVEH-UHFFFAOYSA-N 3-[[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]phenyl]methylamino]propan-1-ol Chemical compound COC1=CC=C(Br)C=C1CSC1=CC=CC=C1CNCCCO YHFJHNVCVXVVEH-UHFFFAOYSA-N 0.000 description 1
125000006275 3-bromophenyl group Chemical group [H]C1=C([H])C(Br)=C([H])C(*)=C1[H] 0.000 description 1
125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 description 1
125000004180 3-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(F)=C1[H] 0.000 description 1
125000006305 3-iodophenyl group Chemical group [H]C1=C([H])C(I)=C([H])C(*)=C1[H] 0.000 description 1
PEPBFCOIJRULGJ-UHFFFAOYSA-N 3h-1,2,3-benzodioxazole Chemical compound C1=CC=C2NOOC2=C1 PEPBFCOIJRULGJ-UHFFFAOYSA-N 0.000 description 1
BWCDLEQTELFBAW-UHFFFAOYSA-N 3h-dioxazole Chemical compound N1OOC=C1 BWCDLEQTELFBAW-UHFFFAOYSA-N 0.000 description 1
OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
DPFXKTGLDWZZBP-UHFFFAOYSA-N 4-(4-chlorophenyl)imidazolidine Chemical compound C1=CC(Cl)=CC=C1C1NCNC1 DPFXKTGLDWZZBP-UHFFFAOYSA-N 0.000 description 1
QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
RQCGBMCXRYEWNS-UHFFFAOYSA-N 4-[[2-(1,4,5,6-tetrahydropyrimidin-2-yl)phenyl]sulfanylmethyl]quinoline Chemical compound C=1C=NC2=CC=CC=C2C=1CSC1=CC=CC=C1C1=NCCCN1 RQCGBMCXRYEWNS-UHFFFAOYSA-N 0.000 description 1
125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 description 1
LCPGBTISTIGVED-UHFFFAOYSA-N 4-tert-butyl-n-(naphthalen-1-ylmethyl)-n-(2-piperidin-1-ylethyl)benzamide Chemical compound C1=CC(C(C)(C)C)=CC=C1C(=O)N(CC=1C2=CC=CC=C2C=CC=1)CCN1CCCCC1 LCPGBTISTIGVED-UHFFFAOYSA-N 0.000 description 1
MEAIANTWONFBMR-UHFFFAOYSA-N 5,5-dimethyl-2-[2-(2-naphthalen-1-ylethyl)phenyl]-1,4-dihydroimidazole Chemical compound N1C(C)(C)CN=C1C1=CC=CC=C1CCC1=CC=CC2=CC=CC=C12 MEAIANTWONFBMR-UHFFFAOYSA-N 0.000 description 1
NVWMBFHESONALO-UHFFFAOYSA-N 5-bromo-2-methoxybenzenethiol Chemical compound COC1=CC=C(Br)C=C1S NVWMBFHESONALO-UHFFFAOYSA-N 0.000 description 1
FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
208000030507 AIDS Diseases 0.000 description 1
239000000275 Adrenocorticotropic Hormone Substances 0.000 description 1
101710115814 Adrenocorticotropic hormone receptor Proteins 0.000 description 1
101710186708 Agglutinin Proteins 0.000 description 1
239000005995 Aluminium silicate Substances 0.000 description 1
BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
TUDGFVWIANUVFB-UHFFFAOYSA-N CC1=C(C2=C(S1)C=CC=N2)C(=O)OC Chemical compound CC1=C(C2=C(S1)C=CC=N2)C(=O)OC TUDGFVWIANUVFB-UHFFFAOYSA-N 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
241000283707 Capra Species 0.000 description 1
BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
241000282693 Cercopithecidae Species 0.000 description 1
JZUFKLXOESDKRF-UHFFFAOYSA-N Chlorothiazide Chemical group C1=C(Cl)C(S(=O)(=O)N)=CC2=C1NCNS2(=O)=O JZUFKLXOESDKRF-UHFFFAOYSA-N 0.000 description 1
229920002261 Corn starch Polymers 0.000 description 1
108010074311 Corticotropin Receptors Proteins 0.000 description 1
229920002785 Croscarmellose sodium Polymers 0.000 description 1
XZMCDFZZKTWFGF-UHFFFAOYSA-N Cyanamide Chemical compound NC#N XZMCDFZZKTWFGF-UHFFFAOYSA-N 0.000 description 1
102000008130 Cyclic AMP-Dependent Protein Kinases Human genes 0.000 description 1
108010049894 Cyclic AMP-Dependent Protein Kinases Proteins 0.000 description 1
239000006144 Dulbecco’s modiﬁed Eagle's medium Substances 0.000 description 1
LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
241000283073 Equus caballus Species 0.000 description 1
239000001856 Ethyl cellulose Substances 0.000 description 1
ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
241000282326 Felis catus Species 0.000 description 1
239000004606 Fillers/Extenders Substances 0.000 description 1
VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Polymers OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 1
239000004705 High-molecular-weight polyethylene Substances 0.000 description 1
241000282412 Homo Species 0.000 description 1
101100129530 Homo sapiens MC4R gene Proteins 0.000 description 1
101000978418 Homo sapiens Melanocortin receptor 4 Proteins 0.000 description 1
101710146024 Horcolin Proteins 0.000 description 1
229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 1
239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 1
235000000072 L-ascorbyl-6-palmitate Nutrition 0.000 description 1
KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
101710189395 Lectin Proteins 0.000 description 1
WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
239000004472 Lysine Substances 0.000 description 1
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
240000003183 Manihot esculenta Species 0.000 description 1
235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 1
229930195725 Mannitol Natural products 0.000 description 1
101710179758 Mannose-specific lectin Proteins 0.000 description 1
101710150763 Mannose-specific lectin 1 Proteins 0.000 description 1
101710150745 Mannose-specific lectin 2 Proteins 0.000 description 1
102000030612 Melanocortin 5 receptor Human genes 0.000 description 1
108010088565 Melanocortin 5 receptor Proteins 0.000 description 1
108010007013 Melanocyte-Stimulating Hormones Proteins 0.000 description 1
AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
229920000168 Microcrystalline cellulose Polymers 0.000 description 1
GQWNECFJGBQMBO-UHFFFAOYSA-N Molindone hydrochloride Chemical compound Cl.O=C1C=2C(CC)=C(C)NC=2CCC1CN1CCOCC1 GQWNECFJGBQMBO-UHFFFAOYSA-N 0.000 description 1
GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
229910002651 NO3 Inorganic materials 0.000 description 1
108090000189 Neuropeptides Proteins 0.000 description 1
102000003797 Neuropeptides Human genes 0.000 description 1
NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
244000131316 Panax pseudoginseng Species 0.000 description 1
235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
235000003140 Panax quinquefolius Nutrition 0.000 description 1
241001494479 Pecora Species 0.000 description 1
241000009328 Perro Species 0.000 description 1
102000004861 Phosphoric Diester Hydrolases Human genes 0.000 description 1
108090001050 Phosphoric Diester Hydrolases Proteins 0.000 description 1
ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical class OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 1
108091000080 Phosphotransferase Proteins 0.000 description 1
229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
239000004952 Polyamide Substances 0.000 description 1
229920000954 Polyglycolide Polymers 0.000 description 1
229920001710 Polyorthoester Polymers 0.000 description 1
102000003946 Prolactin Human genes 0.000 description 1
108010057464 Prolactin Proteins 0.000 description 1
229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
241000700159 Rattus Species 0.000 description 1
108091027981 Response element Proteins 0.000 description 1
241000555745 Sciuridae Species 0.000 description 1
PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
244000061456 Solanum tuberosum Species 0.000 description 1
235000002595 Solanum tuberosum Nutrition 0.000 description 1
235000019486 Sunflower oil Nutrition 0.000 description 1
241000282898 Sus scrofa Species 0.000 description 1
FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
241000282458 Ursus sp. Species 0.000 description 1
235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
HKCYUJLPMMMRCF-UHFFFAOYSA-N [1-[[2-(naphthalen-1-ylsulfanylmethyl)phenyl]methyl]piperidin-2-yl]methanol Chemical compound OCC1CCCCN1CC1=CC=CC=C1CSC1=CC=CC2=CC=CC=C12 HKCYUJLPMMMRCF-UHFFFAOYSA-N 0.000 description 1
XGRRFBZSVWCCNA-UHFFFAOYSA-N [1-[[3-chloro-2-(naphthalen-1-ylsulfanylmethyl)phenyl]methyl]piperidin-2-yl]methanol Chemical compound OCC1CCCCN1CC1=CC=CC(Cl)=C1CSC1=CC=CC2=CC=CC=C12 XGRRFBZSVWCCNA-UHFFFAOYSA-N 0.000 description 1
239000002250 absorbent Substances 0.000 description 1
230000002745 absorbent Effects 0.000 description 1
DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
230000002378 acidificating effect Effects 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
YBCVMFKXIKNREZ-UHFFFAOYSA-N acoh acetic acid Chemical compound CC(O)=O.CC(O)=O YBCVMFKXIKNREZ-UHFFFAOYSA-N 0.000 description 1
239000012190 activator Substances 0.000 description 1
230000010398 acute inflammatory response Effects 0.000 description 1
UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 1
239000002671 adjuvant Substances 0.000 description 1
210000004100 adrenal gland Anatomy 0.000 description 1
230000001780 adrenocortical effect Effects 0.000 description 1
239000000910 agglutinin Substances 0.000 description 1
150000001299 aldehydes Chemical class 0.000 description 1
229940072056 alginate Drugs 0.000 description 1
125000001931 aliphatic group Chemical group 0.000 description 1
239000003513 alkali Substances 0.000 description 1
125000000278 alkyl amino alkyl group Chemical group 0.000 description 1
150000001350 alkyl halides Chemical class 0.000 description 1
125000005087 alkynylcarbonyl group Chemical group 0.000 description 1
125000005198 alkynylcarbonyloxy group Chemical group 0.000 description 1
229940087168 alpha tocopherol Drugs 0.000 description 1
AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
235000012211 aluminium silicate Nutrition 0.000 description 1
229940024545 aluminum hydroxide Drugs 0.000 description 1
229940024548 aluminum oxide Drugs 0.000 description 1
125000005122 aminoalkylamino group Chemical group 0.000 description 1
125000006598 aminocarbonylamino group Chemical group 0.000 description 1
229910021529 ammonia Inorganic materials 0.000 description 1
230000036592 analgesia Effects 0.000 description 1
230000000202 analgesic effect Effects 0.000 description 1
208000022531 anorexia Diseases 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
230000000844 anti-bacterial effect Effects 0.000 description 1
239000003429 antifungal agent Substances 0.000 description 1
229940121375 antifungal agent Drugs 0.000 description 1
230000004596 appetite loss Effects 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
125000006615 aromatic heterocyclic group Chemical group 0.000 description 1
239000010692 aromatic oil Substances 0.000 description 1
238000003491 array Methods 0.000 description 1
RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical class [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
125000002102 aryl alkyloxo group Chemical group 0.000 description 1
235000010323 ascorbic acid Nutrition 0.000 description 1
229960005070 ascorbic acid Drugs 0.000 description 1
239000011668 ascorbic acid Substances 0.000 description 1
125000000477 aza group Chemical group 0.000 description 1
125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 description 1
230000006399 behavior Effects 0.000 description 1
RFRXIWQYSOIBDI-UHFFFAOYSA-N benzarone Chemical compound CCC=1OC2=CC=CC=C2C=1C(=O)C1=CC=C(O)C=C1 RFRXIWQYSOIBDI-UHFFFAOYSA-N 0.000 description 1
125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 1
125000005605 benzo group Chemical group 0.000 description 1
229960002903 benzyl benzoate Drugs 0.000 description 1
230000000035 biogenic effect Effects 0.000 description 1
230000033228 biological regulation Effects 0.000 description 1
125000000319 biphenyl-4-yl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 1
230000000903 blocking effect Effects 0.000 description 1
210000000133 brain stem Anatomy 0.000 description 1
210000005013 brain tissue Anatomy 0.000 description 1
125000001246 bromo group Chemical group Br* 0.000 description 1
239000006172 buffering agent Substances 0.000 description 1
239000001273 butane Substances 0.000 description 1
235000019437 butane-1,3-diol Nutrition 0.000 description 1
125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
125000004744 butyloxycarbonyl group Chemical group 0.000 description 1
238000013262 cAMP assay Methods 0.000 description 1
239000011575 calcium Substances 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
235000010216 calcium carbonate Nutrition 0.000 description 1
229910000019 calcium carbonate Inorganic materials 0.000 description 1
FATUQANACHZLRT-KMRXSBRUSA-L calcium glucoheptonate Chemical class [Ca+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)C([O-])=O FATUQANACHZLRT-KMRXSBRUSA-L 0.000 description 1
159000000007 calcium salts Chemical class 0.000 description 1
239000000378 calcium silicate Substances 0.000 description 1
229910052918 calcium silicate Inorganic materials 0.000 description 1
CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
235000013539 calcium stearate Nutrition 0.000 description 1
239000008116 calcium stearate Substances 0.000 description 1
OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
150000004657 carbamic acid derivatives Chemical class 0.000 description 1
125000003739 carbamimidoyl group Chemical group C(N)(=N)* 0.000 description 1
125000001589 carboacyl group Chemical group 0.000 description 1
235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
239000008112 carboxymethyl-cellulose Substances 0.000 description 1
239000004359 castor oil Substances 0.000 description 1
235000019438 castor oil Nutrition 0.000 description 1
230000001925 catabolic effect Effects 0.000 description 1
239000003054 catalyst Substances 0.000 description 1
239000013592 cell lysate Substances 0.000 description 1
229920002301 cellulose acetate Polymers 0.000 description 1
230000008859 change Effects 0.000 description 1
238000012512 characterization method Methods 0.000 description 1
239000002738 chelating agent Substances 0.000 description 1
238000002512 chemotherapy Methods 0.000 description 1
210000004978 chinese hamster ovary cell Anatomy 0.000 description 1
229960004926 chlorobutanol Drugs 0.000 description 1
125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 1
238000004587 chromatography analysis Methods 0.000 description 1
229960001653 citalopram Drugs 0.000 description 1
239000004927 clay Substances 0.000 description 1
229910052570 clay Inorganic materials 0.000 description 1
238000011260 co-administration Methods 0.000 description 1
210000001072 colon Anatomy 0.000 description 1
238000004040 coloring Methods 0.000 description 1
239000007891 compressed tablet Substances 0.000 description 1
238000007906 compression Methods 0.000 description 1
230000006835 compression Effects 0.000 description 1
239000004020 conductor Substances 0.000 description 1
239000000470 constituent Substances 0.000 description 1
238000013270 controlled release Methods 0.000 description 1
238000001816 cooling Methods 0.000 description 1
239000008120 corn starch Substances 0.000 description 1
150000001907 coumarones Chemical class 0.000 description 1
230000008878 coupling Effects 0.000 description 1
238000010168 coupling process Methods 0.000 description 1
238000005859 coupling reaction Methods 0.000 description 1
239000001767 crosslinked sodium carboxy methyl cellulose Substances 0.000 description 1
235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 description 1
239000012043 crude product Substances 0.000 description 1
238000002425 crystallisation Methods 0.000 description 1
230000008025 crystallization Effects 0.000 description 1
150000001924 cycloalkanes Chemical class 0.000 description 1
125000006448 cycloalkyl cycloalkyl group Chemical group 0.000 description 1
125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
LMKPHJYTFHAGHK-UHFFFAOYSA-N cyclodrine Chemical compound C1CCCC1(O)C(C(=O)OCCN(CC)CC)C1=CC=CC=C1 LMKPHJYTFHAGHK-UHFFFAOYSA-N 0.000 description 1
125000001162 cycloheptenyl group Chemical group C1(=CCCCCC1)* 0.000 description 1
125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 description 1
125000000522 cyclooctenyl group Chemical group C1(=CCCCCCC1)* 0.000 description 1
125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
125000002433 cyclopentenyl group Chemical group C1(=CCCC1)* 0.000 description 1
125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
125000000298 cyclopropenyl group Chemical group [H]C1=C([H])C1([H])* 0.000 description 1
229960001305 cysteine hydrochloride Drugs 0.000 description 1
JHAYEQICABJSTP-UHFFFAOYSA-N decoquinate Chemical group N1C=C(C(=O)OCC)C(=O)C2=C1C=C(OCC)C(OCCCCCCCCCC)=C2 JHAYEQICABJSTP-UHFFFAOYSA-N 0.000 description 1
206010061428 decreased appetite Diseases 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
230000002950 deficient Effects 0.000 description 1
238000012217 deletion Methods 0.000 description 1
230000037430 deletion Effects 0.000 description 1
238000013461 design Methods 0.000 description 1
125000004772 dichloromethyl group Chemical group [H]C(Cl)(Cl)* 0.000 description 1
235000014113 dietary fatty acids Nutrition 0.000 description 1
235000013681 dietary sucrose Nutrition 0.000 description 1
ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
230000004069 differentiation Effects 0.000 description 1
125000004786 difluoromethoxy group Chemical group [H]C(F)(F)O* 0.000 description 1
125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 description 1
229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
239000006185 dispersion Substances 0.000 description 1
238000004090 dissolution Methods 0.000 description 1
238000007876 drug discovery Methods 0.000 description 1
235000013399 edible fruits Nutrition 0.000 description 1
230000001804 emulsifying effect Effects 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
239000002702 enteric coating Substances 0.000 description 1
238000009505 enteric coating Methods 0.000 description 1
238000011067 equilibration Methods 0.000 description 1
230000008029 eradication Effects 0.000 description 1
239000000686 essence Substances 0.000 description 1
125000004185 ester group Chemical group 0.000 description 1
230000032050 esterification Effects 0.000 description 1
238000005886 esterification reaction Methods 0.000 description 1
125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
229940093499 ethyl acetate Drugs 0.000 description 1
235000019325 ethyl cellulose Nutrition 0.000 description 1
229920001249 ethyl cellulose Polymers 0.000 description 1
ZJXZSIYSNXKHEA-UHFFFAOYSA-N ethyl dihydrogen phosphate Chemical compound CCOP(O)(O)=O ZJXZSIYSNXKHEA-UHFFFAOYSA-N 0.000 description 1
LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
229940093471 ethyl oleate Drugs 0.000 description 1
238000001704 evaporation Methods 0.000 description 1
230000008020 evaporation Effects 0.000 description 1
230000029142 excretion Effects 0.000 description 1
210000003499 exocrine gland Anatomy 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
230000006539 extracellular acidification Effects 0.000 description 1
239000003889 eye drop Substances 0.000 description 1
229940012356 eye drops Drugs 0.000 description 1
239000003885 eye ointment Substances 0.000 description 1
239000000194 fatty acid Substances 0.000 description 1
229930195729 fatty acid Natural products 0.000 description 1
150000004665 fatty acids Chemical class 0.000 description 1
230000004634 feeding behavior Effects 0.000 description 1
210000002950 fibroblast Anatomy 0.000 description 1
238000001914 filtration Methods 0.000 description 1
239000005454 flavour additive Substances 0.000 description 1
125000004785 fluoromethoxy group Chemical group [H]C([H])(F)O* 0.000 description 1
239000006260 foam Substances 0.000 description 1
HKIOYBQGHSTUDB-UHFFFAOYSA-N folpet Chemical group C1=CC=C2C(=O)N(SC(Cl)(Cl)Cl)C(=O)C2=C1 HKIOYBQGHSTUDB-UHFFFAOYSA-N 0.000 description 1
235000013305 food Nutrition 0.000 description 1
235000013355 food flavoring agent Nutrition 0.000 description 1
235000019253 formic acid Nutrition 0.000 description 1
210000001035 gastrointestinal tract Anatomy 0.000 description 1
239000007903 gelatin capsule Substances 0.000 description 1
238000007429 general method Methods 0.000 description 1
210000004602 germ cell Anatomy 0.000 description 1
235000008434 ginseng Nutrition 0.000 description 1
ZTQSADJAYQOCDD-UHFFFAOYSA-N ginsenoside-Rd2 Natural products C1CC(C2(CCC3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC(C(C(O)C1O)O)OC1COC1OCC(O)C(O)C1O ZTQSADJAYQOCDD-UHFFFAOYSA-N 0.000 description 1
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 1
SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 1
ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
150000002334 glycols Chemical class 0.000 description 1
239000001963 growth medium Substances 0.000 description 1
125000002795 guanidino group Chemical group C(N)(=N)N* 0.000 description 1
238000003306 harvesting Methods 0.000 description 1
230000036541 health Effects 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 1
238000013537 high throughput screening Methods 0.000 description 1
230000006801 homologous recombination Effects 0.000 description 1
238000002744 homologous recombination Methods 0.000 description 1
239000005556 hormone Substances 0.000 description 1
229940088597 hormone Drugs 0.000 description 1
239000003906 humectant Substances 0.000 description 1
BICAGYDGRXJYGD-UHFFFAOYSA-N hydrobromide;hydrochloride Chemical compound Cl.Br BICAGYDGRXJYGD-UHFFFAOYSA-N 0.000 description 1
QAOWNCQODCNURD-UHFFFAOYSA-M hydrogensulfate Chemical compound OS([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 description 1
WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
239000001863 hydroxypropyl cellulose Substances 0.000 description 1
235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
210000003016 hypothalamus Anatomy 0.000 description 1
AKQZEFRALAUBFS-UHFFFAOYSA-N ilamine Natural products COC(C)C(O)(C(=O)OCC1=CCN2CCCC12)C(C)(C)O AKQZEFRALAUBFS-UHFFFAOYSA-N 0.000 description 1
125000004857 imidazopyridinyl group Chemical group N1C(=NC2=C1C=CC=N2)* 0.000 description 1
150000002466 imines Chemical class 0.000 description 1
238000000099 in vitro assay Methods 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
125000003406 indolizinyl group Chemical class C=1(C=CN2C=CC=CC12)* 0.000 description 1
230000001939 inductive effect Effects 0.000 description 1
230000005764 inhibitory process Effects 0.000 description 1
229940102223 injectable solution Drugs 0.000 description 1
238000001361 intraarterial administration Methods 0.000 description 1
238000007912 intraperitoneal administration Methods 0.000 description 1
239000007928 intraperitoneal injection Substances 0.000 description 1
238000007913 intrathecal administration Methods 0.000 description 1
125000006303 iodophenyl group Chemical group 0.000 description 1
125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
238000002955 isolation Methods 0.000 description 1
125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
239000000644 isotonic solution Substances 0.000 description 1
NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
150000002576 ketones Chemical class 0.000 description 1
238000011813 knockout mouse model Methods 0.000 description 1
JYTUSYBCFIZPBE-AMTLMPIISA-N lactobionic acid Chemical class OC(=O)[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O JYTUSYBCFIZPBE-AMTLMPIISA-N 0.000 description 1
229910052744 lithium Inorganic materials 0.000 description 1
229910003002 lithium salt Inorganic materials 0.000 description 1
159000000002 lithium salts Chemical class 0.000 description 1
210000004185 liver Anatomy 0.000 description 1
208000019017 loss of appetite Diseases 0.000 description 1
235000021266 loss of appetite Nutrition 0.000 description 1
210000004072 lung Anatomy 0.000 description 1
125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
239000000347 magnesium hydroxide Substances 0.000 description 1
229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
159000000003 magnesium salts Chemical class 0.000 description 1
235000019359 magnesium stearate Nutrition 0.000 description 1
VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
210000004962 mammalian cell Anatomy 0.000 description 1
239000000594 mannitol Substances 0.000 description 1
201000001441 melanoma Diseases 0.000 description 1
TWXDDNPPQUTEOV-FVGYRXGTSA-N methamphetamine hydrochloride Chemical compound Cl.CN[C@@H](C)CC1=CC=CC=C1 TWXDDNPPQUTEOV-FVGYRXGTSA-N 0.000 description 1
125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
239000004530 micro-emulsion Substances 0.000 description 1
230000000813 microbial effect Effects 0.000 description 1
239000003094 microcapsule Substances 0.000 description 1
229940016286 microcrystalline cellulose Drugs 0.000 description 1
235000019813 microcrystalline cellulose Nutrition 0.000 description 1
239000008108 microcrystalline cellulose Substances 0.000 description 1
239000004005 microsphere Substances 0.000 description 1
230000000116 mitigating effect Effects 0.000 description 1
238000002156 mixing Methods 0.000 description 1
CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
230000000877 morphologic effect Effects 0.000 description 1
238000000465 moulding Methods 0.000 description 1
PUFRITGIUCXJFV-UHFFFAOYSA-N n,n-dimethyl-n'-(2-naphthalen-1-ylethyl)-n'-(naphthalen-1-ylmethyl)ethane-1,2-diamine Chemical compound C1=CC=C2C(CN(CCC=3C4=CC=CC=C4C=CC=3)CCN(C)C)=CC=CC2=C1 PUFRITGIUCXJFV-UHFFFAOYSA-N 0.000 description 1
GKLFCRUTGQXRHB-UHFFFAOYSA-N n-[2-(3-bromophenyl)ethyl]-n-[(1-ethylpyrrolidin-2-yl)methyl]naphthalen-1-amine Chemical compound CCN1CCCC1CN(C=1C2=CC=CC=C2C=CC=1)CCC1=CC=CC(Br)=C1 GKLFCRUTGQXRHB-UHFFFAOYSA-N 0.000 description 1
URCDELNWRSKOAA-UHFFFAOYSA-N n-[[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]-3-chlorophenyl]methyl]-3-(2-methylpiperidin-1-yl)propan-1-amine Chemical compound COC1=CC=C(Br)C=C1CSC1=C(Cl)C=CC=C1CNCCCN1C(C)CCCC1 URCDELNWRSKOAA-UHFFFAOYSA-N 0.000 description 1
IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
125000005487 naphthalate group Chemical group 0.000 description 1
KVBGVZZKJNLNJU-UHFFFAOYSA-N naphthalene-2-sulfonic acid Chemical compound C1=CC=CC2=CC(S(=O)(=O)O)=CC=C21 KVBGVZZKJNLNJU-UHFFFAOYSA-N 0.000 description 1
230000011234 negative regulation of signal transduction Effects 0.000 description 1
230000002182 neurohumoral effect Effects 0.000 description 1
230000000508 neurotrophic effect Effects 0.000 description 1
150000002825 nitriles Chemical class 0.000 description 1
150000002829 nitrogen Chemical class 0.000 description 1
239000012299 nitrogen atmosphere Substances 0.000 description 1
125000006574 non-aromatic ring group Chemical group 0.000 description 1
231100000344 non-irritating Toxicity 0.000 description 1
125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
239000007764 o/w emulsion Substances 0.000 description 1
QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
229940060184 oil ingredients Drugs 0.000 description 1
239000003605 opacifier Substances 0.000 description 1
239000012044 organic layer Substances 0.000 description 1
210000001672 ovary Anatomy 0.000 description 1
125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
210000000496 pancreas Anatomy 0.000 description 1
239000012188 paraffin wax Substances 0.000 description 1
239000002245 particle Substances 0.000 description 1
125000001148 pentyloxycarbonyl group Chemical group 0.000 description 1
239000000813 peptide hormone Substances 0.000 description 1
102000014187 peptide receptors Human genes 0.000 description 1
108010011903 peptide receptors Proteins 0.000 description 1
125000005004 perfluoroethyl group Chemical group FC(F)(F)C(F)(F)* 0.000 description 1
230000002093 peripheral effect Effects 0.000 description 1
230000000144 pharmacologic effect Effects 0.000 description 1
229950000688 phenothiazine Drugs 0.000 description 1
WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
239000008363 phosphate buffer Substances 0.000 description 1
102000020233 phosphotransferase Human genes 0.000 description 1
230000004962 physiological condition Effects 0.000 description 1
230000001766 physiological effect Effects 0.000 description 1
230000035790 physiological processes and functions Effects 0.000 description 1
239000002504 physiological saline solution Substances 0.000 description 1
239000000902 placebo Substances 0.000 description 1
229940068196 placebo Drugs 0.000 description 1
239000011505 plaster Substances 0.000 description 1
239000002745 poly(ortho ester) Substances 0.000 description 1
229920002647 polyamide Polymers 0.000 description 1
229920001184 polypeptide Polymers 0.000 description 1
229920001451 polypropylene glycol Polymers 0.000 description 1
229920001296 polysiloxane Polymers 0.000 description 1
XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
239000002243 precursor Substances 0.000 description 1
125000001844 prenyl group Chemical group [H]C([*])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
150000003141 primary amines Chemical class 0.000 description 1
239000000651 prodrug Substances 0.000 description 1
229940002612 prodrug Drugs 0.000 description 1
229940097325 prolactin Drugs 0.000 description 1
230000035755 proliferation Effects 0.000 description 1
230000000644 propagated effect Effects 0.000 description 1
239000001294 propane Substances 0.000 description 1
WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical group CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 1
235000013772 propylene glycol Nutrition 0.000 description 1
125000004742 propyloxycarbonyl group Chemical group 0.000 description 1
125000002568 propynyl group Chemical group [*]C#CC([H])([H])[H] 0.000 description 1
230000004952 protein activity Effects 0.000 description 1
239000012264 purified product Substances 0.000 description 1
230000001698 pyrogenic effect Effects 0.000 description 1
125000000719 pyrrolidinyl group Chemical group 0.000 description 1
150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
238000001959 radiotherapy Methods 0.000 description 1
239000000376 reactant Substances 0.000 description 1
239000011541 reaction mixture Substances 0.000 description 1
210000000664 rectum Anatomy 0.000 description 1
YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
229960001860 salicylate Drugs 0.000 description 1
229920006395 saturated elastomer Polymers 0.000 description 1
150000003335 secondary amines Chemical class 0.000 description 1
230000011664 signaling Effects 0.000 description 1
150000004760 silicates Chemical class 0.000 description 1
239000000377 silicon dioxide Substances 0.000 description 1
210000000813 small intestine Anatomy 0.000 description 1
150000003384 small molecules Chemical class 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
229940001607 sodium bisulfite Drugs 0.000 description 1
229910000029 sodium carbonate Inorganic materials 0.000 description 1
235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
239000001509 sodium citrate Substances 0.000 description 1
NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical group O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
229940001584 sodium metabisulfite Drugs 0.000 description 1
235000010262 sodium metabisulphite Nutrition 0.000 description 1
RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 description 1
159000000000 sodium salts Chemical class 0.000 description 1
229910052938 sodium sulfate Inorganic materials 0.000 description 1
229960003010 sodium sulfate Drugs 0.000 description 1
235000011152 sodium sulphate Nutrition 0.000 description 1
210000000278 spinal cord Anatomy 0.000 description 1
239000008223 sterile water Substances 0.000 description 1
230000004936 stimulating effect Effects 0.000 description 1
125000005017 substituted alkenyl group Chemical group 0.000 description 1
KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
239000007940 sugar coated tablet Substances 0.000 description 1
150000008163 sugars Chemical class 0.000 description 1
IIACRCGMVDHOTQ-UHFFFAOYSA-N sulfamic acid Chemical compound NS(O)(=O)=O IIACRCGMVDHOTQ-UHFFFAOYSA-N 0.000 description 1
150000003457 sulfones Chemical class 0.000 description 1
125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
229910021653 sulphate ion Inorganic materials 0.000 description 1
239000002600 sunflower oil Substances 0.000 description 1
239000004094 surface-active agent Substances 0.000 description 1
239000000375 suspending agent Substances 0.000 description 1
230000002459 sustained effect Effects 0.000 description 1
238000013268 sustained release Methods 0.000 description 1
239000012730 sustained-release form Substances 0.000 description 1
238000007910 systemic administration Methods 0.000 description 1
230000008685 targeting Effects 0.000 description 1
239000011975 tartaric acid Substances 0.000 description 1
235000002906 tartaric acid Nutrition 0.000 description 1
229940095064 tartrate Drugs 0.000 description 1
230000028016 temperature homeostasis Effects 0.000 description 1
150000003512 tertiary amines Chemical class 0.000 description 1
125000001302 tertiary amino group Chemical group 0.000 description 1
210000001103 thalamus Anatomy 0.000 description 1
230000004797 therapeutic response Effects 0.000 description 1
125000005309 thioalkoxy group Chemical group 0.000 description 1
125000005032 thiofuranyl group Chemical group S1C(=CC=C1)* 0.000 description 1
NBOMNTLFRHMDEZ-UHFFFAOYSA-N thiosalicylic acid Chemical compound OC(=O)C1=CC=CC=C1S NBOMNTLFRHMDEZ-UHFFFAOYSA-N 0.000 description 1
210000001685 thyroid gland Anatomy 0.000 description 1
210000001519 tissue Anatomy 0.000 description 1
AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
229960000984 tocofersolan Drugs 0.000 description 1
JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
125000003944 tolyl group Chemical group 0.000 description 1
238000011200 topical administration Methods 0.000 description 1
230000009261 transgenic effect Effects 0.000 description 1
LENLQGBLVGGAMF-UHFFFAOYSA-N tributyl([1,2,4]triazolo[1,5-a]pyridin-6-yl)stannane Chemical compound C1=C([Sn](CCCC)(CCCC)CCCC)C=CC2=NC=NN21 LENLQGBLVGGAMF-UHFFFAOYSA-N 0.000 description 1
238000005199 ultracentrifugation Methods 0.000 description 1
229940116269 uric acid Drugs 0.000 description 1
229940070710 valerate Drugs 0.000 description 1
NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 1
230000002792 vascular Effects 0.000 description 1
235000019871 vegetable fat Nutrition 0.000 description 1
239000008158 vegetable oil Substances 0.000 description 1
229920002554 vinyl polymer Polymers 0.000 description 1
239000003039 volatile agent Substances 0.000 description 1
239000007762 w/o emulsion Substances 0.000 description 1
239000011787 zinc oxide Substances 0.000 description 1
239000002076 α-tocopherol Substances 0.000 description 1
235000004835 α-tocopherol Nutrition 0.000 description 1